EX-4.6



 Exhibit 4.6 

13 February 2014 
 Dear Howard 

PRUDENTIAL PLC - LETTER OF APPOINTMENT 
 This letter supersedes your previous
letter of appointment dated 15 October 2010. The Board of Prudential plc (the ‘Company’) appointed you as Non-executive Director with effect from 15 October 2010. I am now writing to set
out the revised terms of your appointment. It is agreed that this is a contract for services subject to the Company’s Articles of Association as amended from time to time and does not constitute a contract of employment. 

Appointment 
 Your appointment was subject to election by shareholders at the
AGM in 2011 and to receipt of all necessary legal and regulatory approvals. Continuation of your appointment will be contingent on satisfactory performance, re-election at forthcoming AGMs and any statutory
provisions relating to the removal of directors. Non-executive Directors are appointed on the understanding that they serve an initial term of three years and, subject to review by the Nomination Committee, a
second term of three years, both subject to annual election at the AGM. After six years of service, Non-executive Directors may be appointed for a further year, up to a maximum of three years, subject to an
annual review by the Nomination Committee. Good governance does not support the practice of serving longer than nine years on the Board as a Non-executive Director. 

If you are not confirmed or re-elected as a director by shareholders, or you are retired from office under the Company’s
Articles of Association, your appointment shall terminate automatically with immediate effect. 
 Participation in Committees 

Non-executive members of the Board are invited to serve on Committees of the Board, as determined by the Board from time to time.
The principal Committees are Audit, Risk, Remuneration and Nomination. The Schedule to this letter, as amended from time to time, lists the Committees of which you are a member. 

  
 1 








 Role 
 Non-executive Directors have the same general legal responsibilities to the Company as any other Director. The Board as a whole is collectively responsible for the success of the Company. The Board: 

 

	•	 	Provides entrepreneurial leadership of the Company within a framework of prudent and effective controls which enable risk to be assessed and managed; 


 

	•	 	Sets the Company’s strategic aims, ensures that the necessary financial, human and other resources are in place for the Company to meet its objectives, and reviews management performance; and 


 

	•	 	Sets the Company’s values and standards and ensures that its obligations to its shareholders and others are understood and met. 


Directors of any company must take decisions objectively in the interests of that company. As a director, you owe a fiduciary duty to the Company, which includes an
obligation not to do anything that might bring it into disrepute. A summary of responsibilities of Directors as applicable to the Company under current legislation will be provided to you. 

In addition to these general requirements of all Directors, the role of the Non-executive Director has the following key
elements: 
  

	 	•	 	Strategy. Non-executive Directors should constructively challenge and help develop proposals on strategy. 


 

	 	•	 	Performance. Non-executive Directors should scrutinise the performance of management in meeting agreed goals and objectives and monitor the reporting of performance. This
is achieved both at the Board and on a more individual level through the Remuneration Committee. 

  

	 	•	 	Risk. Non-executive Directors should satisfy themselves of the integrity of financial information and that financial controls and systems of risk management are robust and
defensible. This is achieved by escalating key issues to the Board either directly or via the Audit Committee. The Group Risk Committee also has an important role in this context. 


 

	 	•	 	People. Non-executive Directors have a prime role in appointing, and where necessary removing, Executive Directors and in succession planning. In addition, they are
responsible for determining appropriate levels of remuneration for Executive Directors. This business is mainly conducted via the Nomination and Remuneration Committees. Non-executive Directors also have a
prime role in upholding high standards of integrity and probity and in supporting the other directors in instilling the appropriate culture, values and behaviours in the boardroom and beyond. 


In this role, you will be a PRA Approved Person, holding a Non-executive Director controlled function (CF2) in respect of The
Prudential Assurance Company Limited (“PAC”). As an Approved Person, you must: 
  

	 	•	 	comply with the Statements of Principle and Code of Practice for Approved Persons (“APER”) set out in the APER section of the PRA Handbook; and 


  
 2 









	 	•	 	meet on an ongoing basis the fit and proper person test for Approved Persons (which covers honesty, integrity and reputation; competence and capability; and financial soundness). 


Group Compliance has provided you with guidance on the obligations of Approved Persons and how these apply to your role as a Controlled Function holder in respect of
PAC. 
 Time Commitment and fees 
 Time commitment will depend on the
Committees on which you serve and may change over time, depending on the issues faced by the business and your time in the role. The Schedule to this letter provides the current time expectations for Board and Committee membership. The Schedule is
reviewed on an annual basis and may be amended from time to time by the Company. 
 Whilst we acknowledge that you have other commitments which may mean you will not
be able to attend all meetings of the Board and relevant Committees, you have confirmed by accepting this appointment that you are able to allocate sufficient time to the Company’s affairs to meet the demands of the role. You must discuss any
additional commitments that might impact on the time you are able to devote to your role as a Non-executive Director of the Company with me prior to accepting. 

Non-executive Directors’ fees are subject to annual review by the Board, and will be in accordance with the policy approved
by shareholders from time to time, as required under the Companies Act 2006 (the “Approved Policy”). Fees accrue on a daily basis and are payable quarterly in arrears. The fees currently payable for Board membership and the additional fees
payable for other Committee memberships are set out in the Schedule to this letter, as amended from time to time. All fees are payable net of any tax and National Insurance contributions, where the Company is required to deduct these. 

As a Non-executive Director you are not entitled to participate in any of the Group’s executive remuneration programmes or
pension arrangements. 
 Directors are entitled to claim for business related expenses properly incurred by them in connection with their attendance at meetings of the
Board or Committees of the Board, general meetings or separate meetings of the holders of any class of shares or of debentures of the Company or otherwise in connection with the discharge of their duties. Documentary evidence of expenses incurred
should be submitted to my office for approval. 
 Shareholding, dealing and compliance 

The 2,500 Prudential qualification shares you purchased within your first year of appointment must be retained during the tenure of your office. 

The Board has also set a shareholding guideline for Non-executive Directors equivalent in value to the basic annual fee. This
shareholding should be acquired within a three-year period of the appointment becoming effective, or from the date of the introduction of the policy if earlier. 

  
 3 








 During your term in office you are subject to Prudential’s Share Dealing Rules, full particulars of which can be found
in the Board Reading Room on your iPad. The rules incorporate all relevant obligations arising from the Company’s listing in HK and the UK, as well as other relevant legislation. These are updated as required to reflect changes in
legislation and regulations, and will provide you with the necessary guidance on the steps you need to take and other considerations relating to share dealings. 
 If
you have any questions on this please consult with Group Secretariat. 
 Conflicts of interests, independence and disclosure obligations 

It is accepted and acknowledged that you have business interests other than those of the Company and we have discussed these and agreed that no conflicts of interest
currently exist (other than those authorised by the Board as part of the appointment process). In the event that you become aware of any future potential conflicts of interest, please disclose these to me and the Company Secretary as soon as
apparent and also prior to accepting appointments. In particular we would not wish our Directors to serve on the Boards of financial services competitors. 
 The Board
of the Company has determined that you are independent according to the provisions of the UK Corporate Governance Code and the Hong Kong Listing Rules, supported by your declaration of independence, and you will be identified as such in the
annual report and other documentation. If you are a member of the Audit Committee, you have also confirmed your independence in respect of the Securities and Exchange Act of 1934 as it applies to members of an audit committee of a Foreign Private
Issuer. If circumstances change, and you believe that your independence may be in doubt, you should discuss this with me as soon as possible. 
 The Company has an
obligation to notify details of other directorships held by its directors during the past five years to various regulators on an annual basis, together with non-statutory offices. Any changes in your external
appointments, including non-statutory offices, should be notified to the Company Secretary on an ongoing basis. In particular, any changes in your directorships of other quoted companies worldwide need to be
notified promptly, preferably the next business day, as the Company is required to announce this to various stock exchanges. 
 Wrongdoing 

You will immediately report to the Board your own wrongdoing or the wrongdoing or proposed wrongdoing of any employee or Director of which you become aware. 

  
 4 








 Termination of appointment 
 The
appointment may be terminated by and at the discretion of either party upon six months’ written notice. On termination of your appointment you shall resign from your office as director of the Company and of any offices you hold in any of the
Company’s group companies. Upon termination you will not be entitled to any compensation, other than accrued pro-rata fees, and you shall also cease to be a member of any Committee of the Board. All
records, documents, accounts, letters and papers of every description (including in particular Board and Committee agendas, minutes and papers) within your possession or control relating to the affairs and business of the Group are and will remain
the property of the Company, and shall be returned to the Company forthwith on termination. 
 Notwithstanding the above, your appointment may be terminated with
immediate effect if you: 
  

	(a)	commit a material breach of your obligations under this letter; or 

  

	(b)	commit any serious or repeated breach or non-observance of your obligations to the Company (which include an obligation not to breach your duties to the Company, whether
statutory, fiduciary or common-law); or 

  

	(c)	are guilty of any fraud or dishonesty or acted in a manner which, in the opinion of the Company acting reasonably, brings or is likely to bring you or the Company into disrepute or is materially adverse to the interests
of the Company; or 

  

	(d)	are convicted of any arrestable criminal offence other than an offence under road traffic legislation in the UK or elsewhere for which a fine or non-custodial penalty is imposed;
or 

  

	(e)	are declared bankrupt or have made an arrangement with or for the benefit of your creditors; or 

  

	(f)	are disqualified from acting as a director; 

  

	(g)	cease to hold PRA Approved Person status ; or 

  

	(h)	do not comply with the Group Anti-Bribery and Corruption Policy. 

 Confidentiality 

During your appointment you will have access to confidential information regarding the business and financial affairs of the Company and those of its subsidiaries,
undertakings and affiliates. You must not, either during your appointment or afterwards, disclose to anyone or otherwise make use of this confidential information, except in the proper performance of your duties or as may be required by law or by
any competent regulatory body. This does not apply, however, to any information already in the public domain. 

  
 5 








 Your attention is also drawn to the requirements under both legislation and regulation as to the disclosure of price
sensitive information. Consequently you should avoid making any statements that might risk a breach of these requirements without prior clearance from me or the Company Secretary. 

Data Protection 
 By signing this letter, you consent to the Company holding and
processing information about you for legal, personnel, administrative and management purposes and in particular to the processing of any sensitive personal data (as defined in the Data Protection Act 1998) including, as appropriate: 

 

	(a)	your racial or ethnic origin or religious or similar beliefs in order to monitor compliance with equal opportunities legislation; or 


 

	(b)	information relating to any criminal proceedings in which you have been involved for insurance purposes and in order to comply with legal requirements and obligations to third parties. 


You consent to the Company making such information available to any of its group companies, those who provide products or services to the Company (such as advisers and
payroll administrators), regulatory authorities, potential or future employers, governmental or quasi-governmental organisations and potential purchasers of the Company. 

You also consent to the transfer of such information to the Company’s business contacts outside the European Economic Area in order to further its business
interests. 
 Induction 
 Following your appointment, the Company provided an
induction programme which included meetings with senior management and the Company’s auditor and focussed on areas of specific interest to you. As part of your induction and during your term in office you received briefings on your duties as a
director generally and as a director of a company listed in the UK and HK. You also subsequently received a briefing on your obligations as a PRA Approved Person. 

Board evaluation 
 The performance of individual Directors and the whole Board
and its Committees is evaluated annually. If, in the interim, there are any matters which cause you concern about your role you should discuss them with me as soon as is appropriate. 

  
 6 








 Professional development 
 As a
Director you are invited to appropriate educational and/or professional development programmes from time to time. The Company Secretary will consult each director annually to ascertain their specific professional development needs. 

Directors’ and officers’ protection 
 The Company has directors’
and officers’ liability insurance and it is intended to maintain such cover for the full term of your appointment. A brief summary of the cover can be found in Prudential’s Guidance Notes for Directors, which is updated on a regular basis.

 The Company has also provided you with indemnity cover for directors’ and officers’ liability within the limitations imposed by law. In addition, the
Company will provide you with a limited indemnity for certain personal liabilities you may suffer in the course of your appointment, subject again to applicable statutory and other limitations, pursuant to the Company’s constitutional documents
or otherwise. 
 The Board has also resolved to have a discretionary payments policy (subject to regular review), the existence of which Directors (executive and non-executive) and certain employees or members of the Prudential Group may rely on, to protect them from personal liability arising out of the bona fide performance of their duties on behalf of the Group. 

Independent professional advice 
 Occasions may arise when you consider that you
need professional advice in the furtherance of your duties as a Director, and it may be appropriate for you to seek advice from independent advisers at the Company’s expense. This would normally be arranged through the Company Secretary. The
Company will reimburse the full cost of expenditure incurred in accordance with the policy. Details of the agreed procedure under which Directors may obtain such independent advice can be found in the Prudential Guidance Notes for Directors. 

Governing law and jurisdiction 
 This letter and any non-contractual obligations arising out of or in connection with it shall be governed by English law. The English courts have exclusive jurisdiction to settle any dispute arising in respect of it. 

Yours sincerely 
 /s/ Paul Manduca 

Paul Manduca 
 Chairman 

Prudential plc 

  
 7 








 Acknowledgement: 
  

	1.	By signing this letter, I agree to its terms. 

  

	2.	I acknowledge that this appointment letter does not constitute a contract of employment. 

  

	3.	I confirm that by having accepted this appointment, I am able to allocate sufficient time to meet the demands of the role. 


Signed: /s/ Howard Davies 
 Dated: February 2014 

  
 8 








 Sir Howard Davies 

Schedule 1 – Committee memberships as at 1 July 2016 
  

	 	•	 	Risk Committee (Chairman) 

  

	 	•	 	Audit Committee 

  

	 	•	 	Nomination Committee 

 Schedule 2 – time commitment and fees as at 1 July 2016 

 

									
	 	  	 	  	Number of
regular
scheduled
meetings	  	Approximate
time
commitment	  	 Fees per
annum

	 Board
	  		  	8	  	31 days	  	£95,000
	 Audit Committee
	  	Chairman Member	  	5	  	22.5-27.5 days
 15 days
	  	£75,000 £27,500
	 Risk Committee
	  	Chairman Member	  	5	  	19-24 days
 7.5 days
	  	£75,000 £27,500
	 Remuneration Committee
	  	Chairman Member	  	4	  	18-23 days
 5 days
	  	£60,000 £27,500
	 Nomination Committee
	  	Member	  	2	  	4 days	  	£10,000
	 Senior Independent Director
	  		  		  	10-25 days	  	£50,000

 Note: 
 In addition to the regular scheduled
meetings, the Committees may hold additional shorter meetings as relevant to discuss, for example, periodic financial reports, succession planning and other issues as they arise. 

  
 9 








 Exhibit 4.6 

13 February 2014 
 Dear Ann, 

PRUDENTIAL PLC - LETTER OF APPOINTMENT 
 This letter supersedes your previous
letter of appointment dated 2 August 2007. The Board of Prudential plc (the ‘Company’) appointed you as Non-executive Director with effect from 2 August 2007. I am now writing to set out the revised terms of your appointment. It
is agreed that this is a contract for services subject to the Company’s Articles of Association as amended from time to time and does not constitute a contract of employment. 

Appointment 
 Your appointment was subject to election by shareholders at the
AGM in 2008 and to receipt of all necessary legal and regulatory approvals. Continuation of your appointment will be contingent on satisfactory performance, re-election at forthcoming AGMs and any statutory provisions relating to the removal of
directors. Non-executive Directors are appointed on the understanding that they serve an initial term of three years and, subject to review by the Nomination Committee, a second term of three years, both subject to annual election at the AGM. After
six years of service, Non-executive Directors may be appointed for a further year, up to a maximum of three years, subject to an annual review by the Nomination Committee. Good governance does not support the practice of serving longer than nine
years on the Board as a Non-executive Director. 
 If you are not confirmed or re-elected as a director by shareholders, or you are retired from office under the
Company’s Articles of Association, your appointment shall terminate automatically with immediate effect. 
 Participation in Committees 

Non-executive members of the Board are invited to serve on Committees of the Board, as determined by the Board from time to time. The principal Committees are Audit,
Risk, Remuneration and Nomination. The Schedule to this letter, as amended from time to time, lists the Committees of which you are a member. 
 Role 

Non-executive Directors have the same general legal responsibilities to the Company as any other Director. The Board as a whole is collectively responsible for the
success of the Company. The Board: 

  
 10 









	•	 	Provides entrepreneurial leadership of the Company within a framework of prudent and effective controls which enable risk to be assessed and managed; 


 

	•	 	Sets the Company’s strategic aims, ensures that the necessary financial, human and other resources are in place for the Company to meet its objectives, and reviews management performance; and 


 

	•	 	Sets the Company’s values and standards and ensures that its obligations to its shareholders and others are understood and met. 


Directors of any company must take decisions objectively in the interests of that company. As a director, you owe a fiduciary duty to the Company, which includes an
obligation not to do anything that might bring it into disrepute. A summary of responsibilities of Directors as applicable to the Company under current legislation will be provided to you. 

In addition to these general requirements of all Directors, the role of the Non-executive Director has the following key elements: 

 

	 	•	 	Strategy. Non-executive Directors should constructively challenge and help develop proposals on strategy. 

  

	 	•	 	Performance. Non-executive Directors should scrutinise the performance of management in meeting agreed goals and objectives and monitor the reporting of performance. This is achieved both at the Board and on a
more individual level through the Remuneration Committee. 

  

	 	•	 	Risk. Non-executive Directors should satisfy themselves of the integrity of financial information and that financial controls and systems of risk management are robust and defensible. This is achieved by
escalating key issues to the Board either directly or via the Audit Committee. The Group Risk Committee also has an important role in this context. 

  

	 	•	 	People. Non-executive Directors have a prime role in appointing, and where necessary removing, Executive Directors and in succession planning. In addition, they are responsible for determining appropriate levels
of remuneration for Executive Directors. This business is mainly conducted via the Nomination and Remuneration Committees. Non-executive Directors also have a prime role in upholding high standards of integrity and probity and in supporting the
other directors in instilling the appropriate culture, values and behaviours in the boardroom and beyond. 

 In this role, you will be a PRA Approved
Person, holding a Non-executive Director controlled function (CF2) in respect of The Prudential Assurance Company Limited (“PAC”). As an Approved Person, you must: 
  

	 	•	 	comply with the Statements of Principle and Code of Practice for Approved Persons (“APER”) set out in the APER section of the PRA Handbook; and 


 

	 	•	 	meet on an ongoing basis the fit and proper person test for Approved Persons (which covers honesty, integrity and reputation; competence and capability; and financial soundness). 


Group Compliance has provided you with guidance on the obligations of Approved Persons and how these apply to your role as a Controlled Function holder in respect of
PAC. 

  
 11 








 Time Commitment and fees 
 Time
commitment will depend on the Committees on which you serve and may change over time, depending on the issues faced by the business and your time in the role. The Schedule to this letter provides the current time expectations for Board and Committee
membership. The Schedule is reviewed on an annual basis and may be amended from time to time by the Company. 
 Whilst we acknowledge that you have other commitments
which may mean you will not be able to attend all meetings of the Board and relevant Committees, you have confirmed by accepting this appointment that you are able to allocate sufficient time to the Company’s affairs to meet the demands of the
role. You must discuss any additional commitments that might impact on the time you are able to devote to your role as a Non-executive Director of the Company with me prior to accepting. 

Non-executive Directors’ fees are subject to annual review by the Board, and will be in accordance with the policy approved by shareholders from time to time, as
required under the Companies Act 2006 (the “Approved Policy”). Fees accrue on a daily basis and are payable quarterly in arrears. The fees currently payable for Board membership and the additional fees payable for other Committee
memberships are set out in the Schedule to this letter, as amended from time to time. All fees are payable net of any tax and National Insurance contributions, where the Company is required to deduct these. 

As a Non-executive Director you are not entitled to participate in any of the Group’s executive remuneration programmes or pension arrangements. 

Directors are entitled to claim for business related expenses properly incurred by them in connection with their attendance at meetings of the Board or Committees of the
Board, general meetings or separate meetings of the holders of any class of shares or of debentures of the Company or otherwise in connection with the discharge of their duties. Documentary evidence of expenses incurred should be submitted to my
office for approval. 
 Shareholding, dealing and compliance 
 The 2,500
Prudential qualification shares you purchased within your first year of appointment must be retained during the tenure of your office. 
 The Board has also set a
shareholding guideline for Non-executive Directors equivalent in value to the basic annual fee. This shareholding should be acquired within a three-year period of the appointment becoming effective, or from the date of the introduction of the policy
if earlier. 
 During your term in office you are subject to Prudential’s Share Dealing Rules, full particulars of which can be found in the Board Reading Room on
your iPad. The rules incorporate all relevant obligations arising from the Company’s listing in HK and the UK, as well as other relevant legislation. These are updated as required to reflect changes in legislation and regulations, and will
provide you with the necessary guidance on the steps you need to take and other considerations relating to share dealings. 
 If you have any questions on this please
consult with Group Secretariat. 

  
 12 








 Conflicts of interests, independence and disclosure obligations 

It is accepted and acknowledged that you have business interests other than those of the Company and we have discussed these and agreed that no conflicts of interest
currently exist (other than those authorised by the Board as part of the appointment process). In the event that you become aware of any future potential conflicts of interest, please disclose these to me and the Company Secretary as soon as
apparent and also prior to accepting appointments. In particular we would not wish our Directors to serve on the Boards of financial services competitors. 
 The Board
of the Company has determined that you are independent according to the provisions of the UK Corporate Governance Code and the Hong Kong Listing Rules, supported by your declaration of independence, and you will be identified as such in the annual
report and other documentation. If you are a member of the Audit Committee, you have also confirmed your independence in respect of the Securities and Exchange Act of 1934 as it applies to members of an audit committee of a Foreign Private Issuer.
If circumstances change, and you believe that your independence may be in doubt, you should discuss this with me as soon as possible. 
 The Company has an obligation
to notify details of other directorships held by its directors during the past five years to various regulators on an annual basis, together with non-statutory offices. Any changes in your external appointments, including non-statutory offices,
should be notified to the Company Secretary on an ongoing basis. In particular, any changes in your directorships of other quoted companies worldwide need to be notified promptly, preferably the next business day, as the Company is required to
announce this to various stock exchanges. 
 Wrongdoing 
 You will immediately
report to the Board your own wrongdoing or the wrongdoing or proposed wrongdoing of any employee or Director of which you become aware. 
 Termination of
appointment 
 The appointment may be terminated by and at the discretion of either party upon six months’ written notice. On termination of your appointment
you shall resign from your office as director of the Company and of any offices you hold in any of the Company’s group companies. Upon termination you will not be entitled to any compensation, other than accrued pro-rata fees, and you shall
also cease to be a member of any Committee of the Board. All records, documents, accounts, letters and papers of every description (including in particular Board and Committee agendas, minutes and papers) within your possession or control relating
to the affairs and business of the Group are and will remain the property of the Company, and shall be returned to the Company forthwith on termination. 

Notwithstanding the above, your appointment may be terminated with immediate effect if you: 
  

	(a)	commit a material breach of your obligations under this letter; or 


  
 13 









	(b)	commit any serious or repeated breach or non-observance of your obligations to the Company (which include an obligation not to breach your duties to the Company, whether statutory, fiduciary or common-law); or


  

	(c)	are guilty of any fraud or dishonesty or acted in a manner which, in the opinion of the Company acting reasonably, brings or is likely to bring you or the Company into disrepute or is materially adverse to the interests
of the Company; or 

  

	(d)	are convicted of any arrestable criminal offence other than an offence under road traffic legislation in the UK or elsewhere for which a fine or non-custodial penalty is imposed; or 


 

	(e)	are declared bankrupt or have made an arrangement with or for the benefit of your creditors; or 

  

	(f)	are disqualified from acting as a director; 

  

	(g)	cease to hold PRA Approved Person status ; or 

  

	(h)	do not comply with the Group Anti-Bribery and Corruption Policy. 

 Confidentiality 

During your appointment you will have access to confidential information regarding the business and financial affairs of the Company and those of its subsidiaries,
undertakings and affiliates. You must not, either during your appointment or afterwards, disclose to anyone or otherwise make use of this confidential information, except in the proper performance of your duties or as may be required by law or by
any competent regulatory body. This does not apply, however, to any information already in the public domain. 
 Your attention is also drawn to the requirements under
both legislation and regulation as to the disclosure of price sensitive information. Consequently you should avoid making any statements that might risk a breach of these requirements without prior clearance from me or the Company Secretary. 

Data Protection 
 By signing this letter, you consent to the Company holding and
processing information about you for legal, personnel, administrative and management purposes and in particular to the processing of any sensitive personal data (as defined in the Data Protection Act 1998) including, as appropriate: 

 

	(a)	your racial or ethnic origin or religious or similar beliefs in order to monitor compliance with equal opportunities legislation; or 


 

	(b)	information relating to any criminal proceedings in which you have been involved for insurance purposes and in order to comply with legal requirements and obligations to third parties. 


You consent to the Company making such information available to any of its group companies, those who provide products or services to the Company (such as advisers and
payroll administrators), regulatory authorities, potential or future employers, governmental or quasi-governmental organisations and potential purchasers of the Company. 

  
 14 








 You also consent to the transfer of such information to the Company’s business contacts outside the European Economic
Area in order to further its business interests. 
 Induction 
 Following your
appointment, the Company provided an induction programme which included meetings with senior management and the Company’s auditor and focussed on areas of specific interest to you. As part of your induction and during your term in office you
received briefings on your duties as a director generally and as a director of a company listed in the UK and HK. You also subsequently received a briefing on your obligations as a PRA Approved Person. 

Board evaluation 
 The performance of individual Directors and the whole Board
and its Committees is evaluated annually. If, in the interim, there are any matters which cause you concern about your role you should discuss them with me as soon as is appropriate. 

Professional development 
 As a Director you are invited to appropriate
educational and/or professional development programmes from time to time. The Company Secretary will consult each director annually to ascertain their specific professional development needs. 

Directors’ and officers’ protection 
 The Company has directors’
and officers’ liability insurance and it is intended to maintain such cover for the full term of your appointment. A brief summary of the cover can be found in Prudential’s Guidance Notes for Directors, which is updated on a regular basis.

 The Company has also provided you with indemnity cover for directors’ and officers’ liability within the limitations imposed by law. In addition, the
Company will provide you with a limited indemnity for certain personal liabilities you may suffer in the course of your appointment, subject again to applicable statutory and other limitations, pursuant to the Company’s constitutional documents
or otherwise. 
 The Board has also resolved to have a discretionary payments policy (subject to regular review), the existence of which Directors (executive and
non-executive) and certain employees or members of the Prudential Group may rely on, to protect them from personal liability arising out of the bona fide performance of their duties on behalf of the Group. 

  
 15 








 Independent professional advice 

Occasions may arise when you consider that you need professional advice in the furtherance of your duties as a Director, and it may be appropriate for you to seek advice
from independent advisers at the Company’s expense. This would normally be arranged through the Company Secretary. The Company will reimburse the full cost of expenditure incurred in accordance with the policy. Details of the agreed procedure
under which Directors may obtain such independent advice can be found in the Prudential Guidance Notes for Directors. 
 Governing law and jurisdiction 

This letter and any non-contractual obligations arising out of or in connection with it shall be governed by English law. The English courts have exclusive jurisdiction
to settle any dispute arising in respect of it. 
 Yours sincerely 
 /s/ Paul
Manduca 
 Paul Manduca 
 Chairman 

Prudential plc 

  
 16 








 Acknowledgement: 
  

	1.	By signing this letter, I agree to its terms. 

  

	2.	I acknowledge that this appointment letter does not constitute a contract of employment. 

  

	3.	I confirm that by having accepted this appointment, I am able to allocate sufficient time to meet the demands of the role. 


Signed: /s/ Ann Godbehere 
 Dated: February 2014 

  
 17 








 Ann Godbehere 

Schedule 1 – Committee memberships as at 1 July 2016 
  

	 	•	 	Audit Committee (Chairman) 

  

	 	•	 	Risk Committee 

  

	 	•	 	Nomination Committee 

 Schedule 2 – time commitment and fees as at 1 July 2016 

 

											
	 	  	 	  	Number of
regular
scheduled
meetings	 	  	Approximate
time
commitment	  	 Fees per
annum

	 Board
	  		  	 	8	 	  	31 days	  	£95,000
	 Audit Committee
	  	Chairman Member	  	 	5	 	  	22.5-27.5 days
 15 days
	  	£75,000 £27,500
	 Risk Committee
	  	Chairman Member	  	 	5	 	  	19-24 days
 7.5 days
	  	£75,000 £27,500
	 Remuneration Committee
	  	Chairman Member	  	 	4	 	  	18-23 days
 5 days
	  	£60,000 £27,500
	 Nomination Committee
	  	Member	  	 	2	 	  	4 days	  	£10,000
	 Senior Independent Director
	  		  				  	10-25 days	  	£50,000

 Note: 
 In addition to the regular scheduled
meetings, the Committees may hold additional shorter meetings as relevant to discuss, for example, periodic financial reports, succession planning and other issues as they arise. 

  
 18 








 Exhibit 4.6 

17 September 2015 
 Dear David 

PRUDENTIAL PLC - LETTER OF APPOINTMENT 
 I am delighted to confirm that the
Board of Prudential plc (the ‘Company’) has agreed to appoint you as Non-executive Director and member of the Audit Committee with effect from 15 September 2015. 

I am now writing to set out the terms of your appointment. It is agreed that this is a contract for services subject to the Company’s Articles of Association as
amended from time to time and does not constitute a contract of employment. 
 Appointment 

Your appointment is subject to election by shareholders at the AGM in 2016 and to receipt of all necessary legal and regulatory approvals. Continuation of your
appointment will be contingent on satisfactory performance, re-election at forthcoming AGMs and any statutory provisions relating to the removal of directors.
Non-executive Directors are appointed on the understanding that they serve an initial term of three years and, subject to review by the Nomination Committee, a second term of three years, both subject to
annual election at the AGM. After six years of service, Non-executive Directors may be appointed for a further year, up to a maximum of three years, subject to an annual review by the Nomination Committee.
Good governance does not support the practice of serving longer than nine years on the Board as a Non-executive Director. 
 If
you are not confirmed or re-elected as a director by shareholders, or you are retired from office under the Company’s Articles of Association, your appointment shall terminate automatically with immediate
effect. 
 Participation in Committees 

Non-executive members of the Board are invited to serve on Committees of the Board, as determined by the Board from time to time.
The principal Committees are Audit, Risk, Remuneration and Nomination. The Schedule to this letter, as amended from time to time, lists the Committees of which you are a member. 

Role 
 Non-executive Directors have the
same general legal responsibilities to the Company as any other Director. The Board as a whole is collectively responsible for the success of the Company. The Board: 

  
 19 









	•	 	Provides entrepreneurial leadership of the Company within a framework of prudent and effective controls which enable risk to be assessed and managed; 


 

	•	 	Sets the Company’s strategic aims, ensures that the necessary financial, human and other resources are in place for the Company to meet its objectives, and reviews management performance; and 


 

	•	 	Sets the Company’s values and standards and ensures that its obligations to its shareholders and others are understood and met. 


Directors of any company must take decisions objectively in the interests of that company. As a director, you owe a fiduciary duty to the Company, which includes an
obligation not to do anything that might bring it into disrepute. A summary of responsibilities of Directors as applicable to the Company under current legislation will be provided to you. 

In addition to these general requirements of all Directors, the role of the Non-executive Director has the following key
elements: 
  

	 	•	 	Strategy. Non-executive Directors should constructively challenge and help develop proposals on strategy. 


 

	 	•	 	Performance. Non-executive Directors should scrutinise the performance of management in meeting agreed goals and objectives and monitor the reporting of performance. This
is achieved both at the Board and on a more individual level through the Remuneration Committee. 

  

	 	•	 	Risk. Non-executive Directors should satisfy themselves of the integrity of financial information and that financial controls and systems of risk management are robust and
defensible. This is achieved by escalating key issues to the Board either directly or via the Audit Committee. The Group Risk Committee also has an important role in this context. 


 

	 	•	 	People. Non-executive Directors have a prime role in appointing, and where necessary removing, Executive Directors and in succession planning. In addition, they are
responsible for determining appropriate levels of remuneration for Executive Directors. This business is mainly conducted via the Nomination and Remuneration Committees. Non-executive Directors also have a
prime role in upholding high standards of integrity and probity and in supporting the other directors in instilling the appropriate culture, values and behaviours in the boardroom and beyond. 


In this role, you are a PRA Approved Person, holding a Non-executive Director controlled function (CF2) in respect of The
Prudential Assurance Company Limited (“PAC”). As an Approved Person, you must: 
  

	 	•	 	comply with the Statements of Principle and Code of Practice for Approved Persons (“APER”) set out in the APER section of the PRA Handbook; and 


 

	 	•	 	meet on an ongoing basis the fit and proper person test for Approved Persons (which covers honesty, integrity and reputation; competence and capability; and financial soundness). 


  
 20 








 Group Compliance will provide you with guidance on the obligations of Approved Persons and how these apply to your role as a
Controlled Function holder in respect of PAC. 
 Time Commitment and fees 

Time commitment will depend on the Committees on which you serve and may change over time, depending on the issues faced by the business and your time in the role. The
Schedule to this letter provides the current time expectations for Board and Committee membership. The Schedule is reviewed on an annual basis and may be amended from time to time by the Company. 

Whilst we acknowledge that you have other commitments which may mean you will not be able to attend all meetings of the Board and relevant Committees, you have confirmed
by accepting this appointment that you are able to allocate sufficient time to the Company’s affairs to meet the demands of the role. You must discuss any additional commitments that might impact on the time you are able to devote to your role
as a Non-executive Director of the Company with me prior to accepting. 
 Non-executive
Directors’ fees are subject to annual review by the Board, and will be in accordance with the policy approved by shareholders from time to time, as required under the Companies Act 2006 (the “Approved Policy”). Fees accrue on a daily
basis and are payable quarterly in arrears. The fees currently payable for Board membership and the additional fees payable for other Committee memberships are set out in the Schedule to this letter, as amended from time to time. All fees are
payable net of any tax and National Insurance contributions, where the Company is required to deduct these. 
 As a
Non-executive Director you are not entitled to participate in any of the Group’s executive remuneration programmes or pension arrangements. 

Directors are entitled to claim for business related expenses properly incurred by them in connection with their attendance at meetings of the Board or Committees of the
Board, general meetings or separate meetings of the holders of any class of shares or of debentures of the Company or otherwise in connection with the discharge of their duties. Documentary evidence of expenses incurred should be submitted to my
office for approval. 
 Shareholding, dealing and compliance 
 You are
required to hold 2,500 qualification shares in Prudential plc, which must be purchased within your first year of appointment must be retained during the tenure of your office. 

The Board has also set a shareholding guideline for Non-executive Directors equivalent in value to the basic annual fee. This
shareholding should be acquired within a three-year period of the appointment becoming effective. 
 During your term in office you are subject to Prudential’s
Share Dealing Rules, full particulars of which can be found in the Board Reading Room on your iPad. The rules incorporate all relevant obligations arising from the Company’s listing in HK and the UK, as 

  
 21 








 well as other relevant legislation. These are updated as required to reflect changes in legislation and regulations,
and will provide you with the necessary guidance on the steps you need to take and other considerations relating to share dealings. 
 If you have any questions on
this please consult with Group Secretariat. 
 Conflicts of interests, independence and disclosure obligations 

It is accepted and acknowledged that you have business interests other than those of the Company and we have discussed these and agreed that no conflicts of interest
currently exist (other than those authorised by the Board as part of the appointment process). In the event that you become aware of any future potential conflicts of interest, please disclose these to me and the Company Secretary as soon as
apparent and also prior to accepting appointments. In particular we would not wish our Directors to serve on the Boards of financial services competitors. 
 The Board
of the Company has determined that you are independent according to the provisions of the UK Corporate Governance Code and you will be identified as such in the annual report and other documentation. If you are a member of the Audit
Committee, you have also confirmed your independence in respect of the Securities and Exchange Act of 1934 as it applies to members of an audit committee of a Foreign Private Issuer. If circumstances change, and you believe that your independence
may be in doubt, you should discuss this with me as soon as possible. 
 For Hong Kong Listing Rule purposes, the Company will consider you independent from
1 July 2016, except in the event of any relevant changes. This will be supported by an independence declaration which you will be asked to provide. 
 The Company
has an obligation to notify details of other directorships held by its directors during the past five years to various regulators on an annual basis, together with non-statutory offices held in a professional
capacity. Any changes in your external appointments, including non-statutory offices, should be notified to the Company Secretary on an ongoing basis. In particular, any changes in your directorships of other
quoted companies worldwide need to be notified promptly, preferably the next business day, as the Company is required to announce this to various stock exchanges. 

Wrongdoing 
 You will immediately report to the Board your own wrongdoing or the
wrongdoing or proposed wrongdoing of any employee or Director of which you become aware. 

  
 22 








 Termination of appointment 
 The
appointment may be terminated by and at the discretion of either party upon six months’ written notice. On termination of your appointment you shall resign from your office as director of the Company and of any offices you hold in any of the
Company’s group companies. Upon termination you will not be entitled to any compensation, other than accrued pro-rata fees, and you shall also cease to be a member of any Committee of the Board. All
records, documents, accounts, letters and papers of every description (including in particular Board and Committee agendas, minutes and papers) within your possession or control relating to the affairs and business of the Group are and will remain
the property of the Company, and shall be returned to the Company forthwith on termination. 
 Notwithstanding the above, your appointment may be terminated with
immediate effect if you: 
  

	(a)	commit a material breach of your obligations under this letter; or 

  

	(b)	commit any serious or repeated breach or non-observance of your obligations to the Company (which include an obligation not to breach your duties to the Company, whether
statutory, fiduciary or common-law); or 

  

	(c)	are guilty of any fraud or dishonesty or acted in a manner which, in the opinion of the Company acting reasonably, brings or is likely to bring you or the Company into disrepute or is materially adverse to the interests
of the Company; or 

  

	(d)	are convicted of any arrestable criminal offence other than an offence under road traffic legislation in the UK or elsewhere for which a fine or non-custodial penalty is imposed;
or 

  

	(e)	are declared bankrupt or have made an arrangement with or for the benefit of your creditors; or 

  

	(f)	are disqualified from acting as a director; or 

  

	(g)	cease to hold PRA Approved Person status ; or 

  

	(h)	do not comply with the Group Anti-Bribery and Corruption Policy. 

 Confidentiality 

During your appointment you will have access to confidential information regarding the business and financial affairs of the Company and those of its subsidiaries,
undertakings and affiliates. You must not, either during your appointment or afterwards, disclose to anyone or otherwise make use of this confidential information, except in the proper performance of your duties or as may be required by law or by
any competent regulatory body. This does not apply, however, to any information already in the public domain. 
 Your attention is also drawn to the requirements under
both legislation and regulation as to the disclosure of price sensitive information. Consequently you should avoid making any statements that might risk a breach of these requirements without prior clearance from me or the Company Secretary. 

  
 23 








 Data Protection 
 By signing this
letter, you consent to the Company holding and processing information about you for legal, personnel, administrative and management purposes and in particular to the processing of any sensitive personal data (as defined in the Data Protection Act
1998) including, as appropriate: 
  

	(a)	your racial or ethnic origin or religious or similar beliefs in order to monitor compliance with equal opportunities legislation; or 


 

	(b)	information relating to any criminal proceedings in which you have been involved for insurance purposes and in order to comply with legal requirements and obligations to third parties. 


You consent to the Company making such information available to any of its group companies, those who provide products or services to the Company (such as advisers and
payroll administrators), regulatory authorities, potential or future employers, governmental or quasi-governmental organisations and potential purchasers of the Company. 

You also consent to the transfer of such information to the Company’s business contacts outside the European Economic Area in order to further its business
interests. 
 Induction 
 Following your appointment, the Company will provide
an induction programme which will include meetings with senior management and the Company’s auditor and will focus on areas of specific interest to you. As part of your induction you will receive a briefing on your duties as a director
generally and as a director of a company listed in the UK and HK. You will also receive a briefing on your obligations as a PRA Approved Person. 
 Board evaluation

 The performance of individual Directors and the whole Board and its Committees is evaluated annually. If, in the interim, there are any matters which cause you
concern about your role you should discuss them with me as soon as is appropriate. 
 Professional development 

As a Director you are invited to appropriate educational and/or professional development programmes from time to time. The Company Secretary will consult each director
annually to ascertain their specific professional development needs. The Company will also provide you with relevant briefings affecting your duties as a director. 

Directors’ and officers’ protection 
 The Company has directors’
and officers’ liability insurance and it is intended to maintain such cover for the full term of your appointment. A brief summary of the cover can be found in Prudential’s Guidance Materials for Directors, which are available on iPad.


  
 24 








 The Company has also provided you with indemnity cover for directors’ and officers’ liability within the
limitations imposed by law. In addition, the Company will provide you with a limited indemnity for certain personal liabilities you may suffer in the course of your appointment, subject again to applicable statutory and other limitations, pursuant
to the Company’s constitutional documents or otherwise. 
 In addition, the Board has resolved to have a discretionary payments policy (subject to regular
review), the existence of which Directors (executive and non-executive) and certain employees or members of the Prudential Group may rely on, to protect them from personal liability arising out of the bona
fide performance of their duties on behalf of the Group. 
 Independent professional advice 

Occasions may arise when you consider that you need professional advice in the furtherance of your duties as a Director, and it may be appropriate for you to seek advice
from independent advisers at the Company’s expense. This would normally be arranged through the Company Secretary. The Company will reimburse the full cost of expenditure incurred in accordance with the policy. Details of the agreed procedure
under which Directors may obtain such independent advice can be found in the Prudential Guidance Materials for Directors. 
 Governing law and jurisdiction 

This letter and any non-contractual obligations arising out of or in connection with it shall be governed by English law. The
English courts have exclusive jurisdiction to settle any dispute arising in respect of it. 
 Yours sincerely 

/s/ Paul Manduca 
 Paul Manduca 

Chairman 
 Prudential plc 

  
 25 








 Acknowledgement: 
  

	1.	By signing this letter, I agree to its terms. 

  

	2.	I acknowledge that this appointment letter does not constitute a contract of employment. 

  

	3.	I confirm that by having accepted this appointment, I am able to allocate sufficient time to meet the demands of the role. 


Signed: /s/ David Law 
 Dated: September 2015 

  
 26 








 David Law 
 Schedule 1
– Committee memberships as at 1 July 2016 
  

	 	•	 	Audit Committee 

 Schedule 2 – time commitment and fees as at 1 July 2016 

 

									
	 	  	 	  	Number of
regular
scheduled
meetings	  	Approximate
time
commitment	  	Fees per
annum
	 Board
	  		  	8	  	31 days	  	£95,000
	 Audit

Committee
	  	Chairman Member	  	5	  	22.5-27.5 days
 15 days
	  	£75,000
 £27,500

	 Risk

Committee
	  	Chairman Member	  	5	  	19-24 days
 7.5 days
	  	£75,000
 £27,500

	 Remuneration

Committee
	  	Chairman Member	  	4	  	18-23 days
 5 days
	  	£60,000
 £27,500

	 Nomination Committee
	  	Member	  	2	  	4 days	  	£10,000
	 Senior Independent Director
	  		  		  	10-25 days	  	£50,000

 Note: 
 In addition to the regular scheduled
meetings, the Committees may hold additional shorter meetings as relevant to discuss, for example, periodic financial reports, succession planning and other issues as they arise. 

  
 27 








 Exhibit 4.6 

13 February 2014 
 Dear Kai 

PRUDENTIAL PLC - LETTER OF APPOINTMENT 
 This letter supersedes your previous
letter of appointment dated 20 December 2011. The Board of Prudential plc (the ‘Company’) appointed you as Non-executive Director with effect from 1 January 2012. I am now writing to set
out the revised terms of your appointment. It is agreed that this is a contract for services subject to the Company’s Articles of Association as amended from time to time and does not constitute a contract of employment. 

Appointment 
 Your appointment was subject to election by shareholders at the
AGM in 2012 and to receipt of all necessary legal and regulatory approvals. Continuation of your appointment will be contingent on satisfactory performance, re-election at forthcoming AGMs and any statutory
provisions relating to the removal of directors. Non-executive Directors are appointed on the understanding that they serve an initial term of three years and, subject to review by the Nomination Committee, a
second term of three years, both subject to annual election at the AGM. After six years of service, Non-executive Directors may be appointed for a further year, up to a maximum of three years, subject to an
annual review by the Nomination Committee. Good governance does not support the practice of serving longer than nine years on the Board as a Non-executive Director. 

If you are not confirmed or re-elected as a director by shareholders, or you are retired from office under the Company’s
Articles of Association, your appointment shall terminate automatically with immediate effect. 
 Participation in Committees 

Non-executive members of the Board are invited to serve on Committees of the Board, as determined by the Board from time to time.
The principal Committees are Audit, Risk, Remuneration and Nomination. The Schedule to this letter, as amended from time to time, lists the Committees of which you are a member. 

Role 
 Non-executive Directors have the
same general legal responsibilities to the Company as any other Director. The Board as a whole is collectively responsible for the success of the Company. The Board: 
  

	•	 	Provides entrepreneurial leadership of the Company within a framework of prudent and effective controls which enable risk to be assessed and managed; 


  
 28 









	•	 	Sets the Company’s strategic aims, ensures that the necessary financial, human and other resources are in place for the Company to meet its objectives, and reviews management performance; and 


 

	•	 	Sets the Company’s values and standards and ensures that its obligations to its shareholders and others are understood and met. 


Directors of any company must take decisions objectively in the interests of that company. As a director, you owe a fiduciary duty to the Company, which includes an
obligation not to do anything that might bring it into disrepute. A summary of responsibilities of Directors as applicable to the Company under current legislation will be provided to you. 

In addition to these general requirements of all Directors, the role of the Non-executive Director has the following key
elements: 
  

	 	•	 	Strategy. Non-executive Directors should constructively challenge and help develop proposals on strategy. 


 

	 	•	 	Performance. Non-executive Directors should scrutinise the performance of management in meeting agreed goals and objectives and monitor the reporting of performance. This
is achieved both at the Board and on a more individual level through the Remuneration Committee. 

  

	 	•	 	Risk. Non-executive Directors should satisfy themselves of the integrity of financial information and that financial controls and systems of risk management are robust and
defensible. This is achieved by escalating key issues to the Board either directly or via the Audit Committee. The Group Risk Committee also has an important role in this context. 


 

	 	•	 	People. Non-executive Directors have a prime role in appointing, and where necessary removing, Executive Directors and in succession planning. In addition, they are
responsible for determining appropriate levels of remuneration for Executive Directors. This business is mainly conducted via the Nomination and Remuneration Committees. Non-executive Directors also have a
prime role in upholding high standards of integrity and probity and in supporting the other directors in instilling the appropriate culture, values and behaviours in the boardroom and beyond. 


In this role, you will be a PRA Approved Person, holding a Non-executive Director controlled function (CF2) in respect of The
Prudential Assurance Company Limited (“PAC”). As an Approved Person, you must: 
  

	 	•	 	comply with the Statements of Principle and Code of Practice for Approved Persons (“APER”) set out in the APER section of the PRA Handbook; and 


 

	 	•	 	meet on an ongoing basis the fit and proper person test for Approved Persons (which covers honesty, integrity and reputation; competence and capability; and financial soundness). 


  
 29 








 Group Compliance has provided you with guidance on the obligations of Approved Persons and how these apply to your role as a
Controlled Function holder in respect of PAC. 
 Time Commitment and fees 

Time commitment will depend on the Committees on which you serve and may change over time, depending on the issues faced by the business and your time in the role. The
Schedule to this letter provides the current time expectations for Board and Committee membership. The Schedule is reviewed on an annual basis and may be amended from time to time by the Company. 

Whilst we acknowledge that you have other commitments which may mean you will not be able to attend all meetings of the Board and relevant Committees, you have confirmed
by accepting this appointment that you are able to allocate sufficient time to the Company’s affairs to meet the demands of the role. You must discuss any additional commitments that might impact on the time you are able to devote to your role
as a Non-executive Director of the Company with me prior to accepting. 
 Non-executive
Directors’ fees are subject to annual review by the Board, and will be in accordance with the policy approved by shareholders from time to time, as required under the Companies Act 2006 (the “Approved Policy”). Fees accrue on a daily
basis and are payable quarterly in arrears. The fees currently payable for Board membership and the additional fees payable for other Committee memberships are set out in the Schedule to this letter, as amended from time to time. All fees are
payable net of any tax and National Insurance contributions, where the Company is required to deduct these. 
 As a
Non-executive Director you are not entitled to participate in any of the Group’s executive remuneration programmes or pension arrangements. 

Directors are entitled to claim for business related expenses properly incurred by them in connection with their attendance at meetings of the Board or Committees of the
Board, general meetings or separate meetings of the holders of any class of shares or of debentures of the Company or otherwise in connection with the discharge of their duties. Documentary evidence of expenses incurred should be submitted to my
office for approval. 
 Shareholding, dealing and compliance 
 The 2,500
Prudential qualification shares you purchased within your first year of appointment must be retained during the tenure of your office. 
 The Board has also set a
shareholding guideline for Non-executive Directors equivalent in value to the basic annual fee. This shareholding should be acquired within a three-year period of the appointment becoming effective, or from
the date of the introduction of the policy if earlier. 
 During your term in office you are subject to Prudential’s Share Dealing Rules, full particulars of
which can be found in the Board Reading Room on your iPad. The rules incorporate all relevant obligations arising from the Company’s listing in HK and the UK, as 

  
 30 








 well as other relevant legislation. These are updated as required to reflect changes in legislation and regulations,
and will provide you with the necessary guidance on the steps you need to take and other considerations relating to share dealings. 
 If you have any questions on
this please consult with Group Secretariat. 
 Conflicts of interests, independence and disclosure obligations 

It is accepted and acknowledged that you have business interests other than those of the Company and we have discussed these and agreed that no conflicts of interest
currently exist (other than those authorised by the Board as part of the appointment process). In the event that you become aware of any future potential conflicts of interest, please disclose these to me and the Company Secretary as soon as
apparent and also prior to accepting appointments. In particular we would not wish our Directors to serve on the Boards of financial services competitors. 
 The Board
of the Company has determined that you are independent according to the provisions of the UK Corporate Governance Code and the Hong Kong Listing Rules, supported by your declaration of independence, and you will be identified as such in the
annual report and other documentation. If you are a member of the Audit Committee, you have also confirmed your independence in respect of the Securities and Exchange Act of 1934 as it applies to members of an audit committee of a Foreign Private
Issuer. If circumstances change, and you believe that your independence may be in doubt, you should discuss this with me as soon as possible. 
 The Company has an
obligation to notify details of other directorships held by its directors during the past five years to various regulators on an annual basis, together with non-statutory offices. Any changes in your external
appointments, including non-statutory offices, should be notified to the Company Secretary on an ongoing basis. In particular, any changes in your directorships of other quoted companies worldwide need to be
notified promptly, preferably the next business day, as the Company is required to announce this to various stock exchanges. 
 Wrongdoing 

You will immediately report to the Board your own wrongdoing or the wrongdoing or proposed wrongdoing of any employee or Director of which you become aware. 

  
 31 








 Termination of appointment 
 The
appointment may be terminated by and at the discretion of either party upon six months’ written notice. On termination of your appointment you shall resign from your office as director of the Company and of any offices you hold in any of the
Company’s group companies. Upon termination you will not be entitled to any compensation, other than accrued pro-rata fees, and you shall also cease to be a member of any Committee of the Board. All records, documents, accounts, letters and
papers of every description (including in particular Board and Committee agendas, minutes and papers) within your possession or control relating to the affairs and business of the Group are and will remain the property of the Company, and shall be
returned to the Company forthwith on termination. 
 Notwithstanding the above, your appointment may be terminated with immediate effect if you: 

 

	(a)	commit a material breach of your obligations under this letter; or 

  

	(b)	commit any serious or repeated breach or non-observance of your obligations to the Company (which include an obligation not to breach your duties to the Company, whether
statutory, fiduciary or common-law); or 

  

	(c)	are guilty of any fraud or dishonesty or acted in a manner which, in the opinion of the Company acting reasonably, brings or is likely to bring you or the Company into disrepute or is materially adverse to the interests
of the Company; or 

  

	(d)	are convicted of any arrestable criminal offence other than an offence under road traffic legislation in the UK or elsewhere for which a fine or non-custodial penalty is imposed;
or 

  

	(e)	are declared bankrupt or have made an arrangement with or for the benefit of your creditors; or 

  

	(f)	are disqualified from acting as a director; 

  

	(g)	cease to hold PRA Approved Person status ; or 

  

	(h)	do not comply with the Group Anti-Bribery and Corruption Policy. 

 Confidentiality 

During your appointment you will have access to confidential information regarding the business and financial affairs of the Company and those of its subsidiaries,
undertakings and affiliates. You must not, either during your appointment or afterwards, disclose to anyone or otherwise make use of this confidential information, except in the proper performance of your duties or as may be required by law or by
any competent regulatory body. This does not apply, however, to any information already in the public domain. 
 Your attention is also drawn to the requirements under
both legislation and regulation as to the disclosure of price sensitive information. Consequently you should avoid making any statements that might risk a breach of these requirements without prior clearance from me or the Company Secretary. 

  
 32 








 Data Protection 
 By signing this
letter, you consent to the Company holding and processing information about you for legal, personnel, administrative and management purposes and in particular to the processing of any sensitive personal data (as defined in the Data Protection Act
1998) including, as appropriate: 
  

	(a)	your racial or ethnic origin or religious or similar beliefs in order to monitor compliance with equal opportunities legislation; or 


 

	(b)	information relating to any criminal proceedings in which you have been involved for insurance purposes and in order to comply with legal requirements and obligations to third parties. 


You consent to the Company making such information available to any of its group companies, those who provide products or services to the Company (such as advisers and
payroll administrators), regulatory authorities, potential or future employers, governmental or quasi-governmental organisations and potential purchasers of the Company. 

You also consent to the transfer of such information to the Company’s business contacts outside the European Economic Area in order to further its business
interests. 
 Induction 
 Following your appointment, the Company provided an
induction programme which included meetings with senior management and the Company’s auditor and focussed on areas of specific interest to you. As part of your induction and during your term in office you received briefings on your duties as a
director generally and as a director of a company listed in the UK and HK. You also subsequently received a briefing on your obligations as a PRA Approved Person. 

Board evaluation 
 The performance of individual Directors and the whole Board
and its Committees is evaluated annually. If, in the interim, there are any matters which cause you concern about your role you should discuss them with me as soon as is appropriate. 

Professional development 
 As a Director you are invited to appropriate
educational and/or professional development programmes from time to time. The Company Secretary will consult each director annually to ascertain their specific professional development needs. 

  
 33 








 Directors’ and officers’ protection 

The Company has directors’ and officers’ liability insurance and it is intended to maintain such cover for the full term of your appointment. A brief summary of
the cover can be found in Prudential’s Guidance Notes for Directors, which is updated on a regular basis. 
 The Company has also provided you with indemnity
cover for directors’ and officers’ liability within the limitations imposed by law. In addition, the Company will provide you with a limited indemnity for certain personal liabilities you may suffer in the course of your appointment,
subject again to applicable statutory and other limitations, pursuant to the Company’s constitutional documents or otherwise. 
 The Board has also resolved to
have a discretionary payments policy (subject to regular review), the existence of which Directors (executive and non-executive) and certain employees or members of the Prudential Group may rely on, to protect
them from personal liability arising out of the bona fide performance of their duties on behalf of the Group. 
 Independent professional advice 

Occasions may arise when you consider that you need professional advice in the furtherance of your duties as a Director, and it may be appropriate for you to seek advice
from independent advisers at the Company’s expense. This would normally be arranged through the Company Secretary. The Company will reimburse the full cost of expenditure incurred in accordance with the policy. Details of the agreed procedure
under which Directors may obtain such independent advice can be found in the Prudential Guidance Notes for Directors. 
 Governing law and jurisdiction 

This letter and any non-contractual obligations arising out of or in connection with it shall be governed by English law. The
English courts have exclusive jurisdiction to settle any dispute arising in respect of it. 
 Yours sincerely 

/s/ Paul Manduca 
 Paul Manduca 

Chairman 
 Prudential plc 

  
 34 








 Acknowledgement: 
  

	1.	By signing this letter, I agree to its terms. 

  

	2.	I acknowledge that this appointment letter does not constitute a contract of employment. 

  

	3.	I confirm that by having accepted this appointment, I am able to allocate sufficient time to meet the demands of the role. 


Signed: /s/ K Nargolwala 
 Dated: March 2014 

  
 35 








 Kai Nargolwala 

Schedule 1 – Committee memberships as at 1 July 2016 
  

	 	•	 	Risk Committee 

  

	 	•	 	Remuneration Committee 

 Schedule 2 – time commitment and fees as at 1 July 2016 

 

											
	 	  	 	 	  	Number of
regular
scheduled
meetings	  	Approximate
time
commitment	  	Fees per
annum
	 Board
	  				  	8	  	31 days	  	£95,000
	 Audit

Committee
	  	 
	Chairman
Member	 
 	  	5	  	22.5-27.5 days
 15 days
	  	£75,000
 £27,500

	 Risk

Committee
	  	 
	Chairman
Member	 
 	  	5	  	19-24 days
 7.5 days
	  	£75,000
 £27,500

	 Remuneration

Committee
	  	 
	Chairman
Member	 
 	  	4	  	18-23 days
 5 days
	  	£60,000
 £27,500

	 Nomination

Committee
	  	 	Member	 	  	2	  	4 days	  	£10,000
	 Senior Independent Director
	  				  		  	10-25 days	  	£50,000

 Note: 
 In addition to the regular scheduled
meetings, the Committees may hold additional shorter meetings as relevant to discuss, for example, periodic financial reports, succession planning and other issues as they arise. 

  
 36 








 Exhibit 4.6 

13 February 2014 
 Dear Anthony, 

PRUDENTIAL PLC - LETTER OF APPOINTMENT 
 This letter supersedes your previous
letter of appointment dated 28 May 2013. The Board of Prudential plc (the ‘Company’) appointed you as Non-executive Director with effect from 1 June 2013. I am now writing to set out the
revised terms of your appointment. It is agreed that this is a contract for services subject to the Company’s Articles of Association as amended from time to time and does not constitute a contract of employment. 

Appointment 
 Your appointment is subject to election by shareholders at the AGM
in 2014 and to receipt of all necessary legal and regulatory approvals. Continuation of your appointment will be contingent on satisfactory performance, re-election at forthcoming AGMs and any statutory
provisions relating to the removal of directors. Non-executive Directors are appointed on the understanding that they serve an initial term of three years and, subject to review by the Nomination Committee, a
second term of three years, both subject to annual election at the AGM. After six years of service, Non-executive Directors may be appointed for a further year, up to a maximum of three years, subject to an
annual review by the Nomination Committee. Good governance does not support the practice of serving longer than nine years on the Board as a Non-executive Director. 

If you are not confirmed or re-elected as a director by shareholders, or you are retired from office under the Company’s
Articles of Association, your appointment shall terminate automatically with immediate effect. 
 Participation in Committees 

Non-executive members of the Board are invited to serve on Committees of the Board, as determined by the Board from time to time.
The principal Committees are Audit, Risk, Remuneration and Nomination. The Schedule to this letter, as amended from time to time, lists the Committees of which you are a member. 

Role 
 Non-executive Directors have the
same general legal responsibilities to the Company as any other Director. The Board as a whole is collectively responsible for the success of the Company. The Board: 

  
 37 









	•	 	Provides entrepreneurial leadership of the Company within a framework of prudent and effective controls which enable risk to be assessed and managed; 


 

	•	 	Sets the Company’s strategic aims, ensures that the necessary financial, human and other resources are in place for the Company to meet its objectives, and reviews management performance; and 


 

	•	 	Sets the Company’s values and standards and ensures that its obligations to its shareholders and others are understood and met. 


Directors of any company must take decisions objectively in the interests of that company. As a director, you owe a fiduciary duty to the Company, which includes an
obligation not to do anything that might bring it into disrepute. A summary of responsibilities of Directors as applicable to the Company under current legislation will be provided to you. 

In addition to these general requirements of all Directors, the role of the Non-executive Director has the following key
elements: 
  

	 	•	 	Strategy. Non-executive Directors should constructively challenge and help develop proposals on strategy. 


 

	 	•	 	Performance. Non-executive Directors should scrutinise the performance of management in meeting agreed goals and objectives and monitor the reporting of performance. This
is achieved both at the Board and on a more individual level through the Remuneration Committee. 

  

	 	•	 	Risk. Non-executive Directors should satisfy themselves of the integrity of financial information and that financial controls and systems of risk management are robust and
defensible. This is achieved by escalating key issues to the Board either directly or via the Audit Committee. The Group Risk Committee also has an important role in this context. 


 

	 	•	 	People. Non-executive Directors have a prime role in appointing, and where necessary removing, Executive Directors and in succession planning. In addition, they are
responsible for determining appropriate levels of remuneration for Executive Directors. This business is mainly conducted via the Nomination and Remuneration Committees. Non-executive Directors also have a
prime role in upholding high standards of integrity and probity and in supporting the other directors in instilling the appropriate culture, values and behaviours in the boardroom and beyond. 


In this role, you will be a PRA Approved Person, holding a Non-executive Director controlled function (CF2) in respect of The
Prudential Assurance Company Limited (“PAC”). As an Approved Person, you must: 
  

	 	•	 	comply with the Statements of Principle and Code of Practice for Approved Persons (“APER”) set out in the APER section of the PRA Handbook; and 


  
 38 









	 	•	 	meet on an ongoing basis the fit and proper person test for Approved Persons (which covers honesty, integrity and reputation; competence and capability; and financial soundness). 


Group Compliance has provided you with guidance on the obligations of Approved Persons and how these apply to your role as a Controlled Function holder in respect of
PAC. 
 Time Commitment and fees 
 Time commitment will depend on the
Committees on which you serve and may change over time, depending on the issues faced by the business and your time in the role. The Schedule to this letter provides the current time expectations for Board and Committee membership. The Schedule is
reviewed on an annual basis and may be amended from time to time by the Company. 
 Whilst we acknowledge that you have other commitments which may mean you will not
be able to attend all meetings of the Board and relevant Committees, you have confirmed by accepting this appointment that you are able to allocate sufficient time to the Company’s affairs to meet the demands of the role. You must discuss any
additional commitments that might impact on the time you are able to devote to your role as a Non-executive Director of the Company with me prior to accepting. 

Non-executive Directors’ fees are subject to annual review by the Board, and will be in accordance with the policy approved
by shareholders from time to time, as required under the Companies Act 2006 (the “Approved Policy”). Fees accrue on a daily basis and are payable quarterly in arrears. The fees currently payable for Board membership and the additional fees
payable for other Committee memberships are set out in the Schedule to this letter, as amended from time to time. All fees are payable net of any tax and National Insurance contributions, where the Company is required to deduct these. 

As a Non-executive Director you are not entitled to participate in any of the Group’s executive remuneration programmes or
pension arrangements. 
 Directors are entitled to claim for business related expenses properly incurred by them in connection with their attendance at meetings of the
Board or Committees of the Board, general meetings or separate meetings of the holders of any class of shares or of debentures of the Company or otherwise in connection with the discharge of their duties. Documentary evidence of expenses incurred
should be submitted to my office for approval. 
 Shareholding, dealing and compliance 

The 2,500 Prudential qualification shares you purchased within your first year of appointment must be retained during the tenure of your office. 

The Board has also set a shareholding guideline for Non-executive Directors equivalent in value to the basic annual fee. This
shareholding should be acquired within a three-year period of the appointment becoming effective, or from the date of the introduction of the policy if earlier. 

  
 39 








 During your term in office you are subject to Prudential’s Share Dealing Rules, full particulars of which can be found
in the Board Reading Room on your iPad. The rules incorporate all relevant obligations arising from the Company’s listing in HK and the UK, as well as other relevant legislation. These are updated as required to reflect changes in
legislation and regulations, and will provide you with the necessary guidance on the steps you need to take and other considerations relating to share dealings. 
 If
you have any questions on this please consult with Group Secretariat. 
 Conflicts of interests, independence and disclosure obligations 

It is accepted and acknowledged that you have business interests other than those of the Company and we have discussed these and agreed that no conflicts of interest
currently exist (other than those authorised by the Board as part of the appointment process). In the event that you become aware of any future potential conflicts of interest, please disclose these to me and the Company Secretary as soon as
apparent and also prior to accepting appointments. In particular we would not wish our Directors to serve on the Boards of financial services competitors. 
 The Board
of the Company has determined that you are independent according to the provisions of the UK Corporate Governance Code and the Hong Kong Listing Rules, supported by your declaration of independence, and you will be identified as such in the
annual report and other documentation. If you are a member of the Audit Committee, you have also confirmed your independence in respect of the Securities and Exchange Act of 1934 as it applies to members of an audit committee of a Foreign Private
Issuer. If circumstances change, and you believe that your independence may be in doubt, you should discuss this with me as soon as possible. 
 The Company has an
obligation to notify details of other directorships held by its directors during the past five years to various regulators on an annual basis, together with non-statutory offices. Any changes in your external
appointments, including non-statutory offices, should be notified to the Company Secretary on an ongoing basis. In particular, any changes in your directorships of other quoted companies worldwide need to be
notified promptly, preferably the next business day, as the Company is required to announce this to various stock exchanges. 
 Wrongdoing 

You will immediately report to the Board your own wrongdoing or the wrongdoing or proposed wrongdoing of any employee or Director of which you become aware. 

  
 40 








 Termination of appointment 
 The
appointment may be terminated by and at the discretion of either party upon six months’ written notice. On termination of your appointment you shall resign from your office as director of the Company and of any offices you hold in any of the
Company’s group companies. Upon termination you will not be entitled to any compensation, other than accrued pro-rata fees, and you shall also cease to be a member of any Committee of the Board. All
records, documents, accounts, letters and papers of every description (including in particular Board and Committee agendas, minutes and papers) within your possession or control relating to the affairs and business of the Group are and will remain
the property of the Company, and shall be returned to the Company forthwith on termination. 
 Notwithstanding the above, your appointment may be terminated with
immediate effect if you: 
  

	(a)	commit a material breach of your obligations under this letter; or 

  

	(b)	commit any serious or repeated breach or non-observance of your obligations to the Company (which include an obligation not to breach your duties to the Company, whether
statutory, fiduciary or common-law); or 

  

	(c)	are guilty of any fraud or dishonesty or acted in a manner which, in the opinion of the Company acting reasonably, brings or is likely to bring you or the Company into disrepute or is materially adverse to the interests
of the Company; or 

  

	(d)	are convicted of any arrestable criminal offence other than an offence under road traffic legislation in the UK or elsewhere for which a fine or non-custodial penalty is imposed;
or 

  

	(e)	are declared bankrupt or have made an arrangement with or for the benefit of your creditors; or 

  

	(f)	are disqualified from acting as a director; 

  

	(g)	cease to hold PRA Approved Person status ; or 

  

	(h)	do not comply with the Group Anti-Bribery and Corruption Policy. 

 Confidentiality 

During your appointment you will have access to confidential information regarding the business and financial affairs of the Company and those of its subsidiaries,
undertakings and affiliates. You must not, either during your appointment or afterwards, disclose to anyone or otherwise make use of this confidential information, except in the proper performance of your duties or as may be required by law or by
any competent regulatory body. This does not apply, however, to any information already in the public domain. 
 Your attention is also drawn to the requirements under
both legislation and regulation as to the disclosure of price sensitive information. Consequently you should avoid making any statements that might risk a breach of these requirements without prior clearance from me or the Company Secretary. 

  
 41 








 Data Protection 
 By signing this
letter, you consent to the Company holding and processing information about you for legal, personnel, administrative and management purposes and in particular to the processing of any sensitive personal data (as defined in the Data Protection Act
1998) including, as appropriate: 
  

	(a)	your racial or ethnic origin or religious or similar beliefs in order to monitor compliance with equal opportunities legislation; or 


 

	(b)	information relating to any criminal proceedings in which you have been involved for insurance purposes and in order to comply with legal requirements and obligations to third parties. 


You consent to the Company making such information available to any of its group companies, those who provide products or services to the Company (such as advisers and
payroll administrators), regulatory authorities, potential or future employers, governmental or quasi-governmental organisations and potential purchasers of the Company. 

You also consent to the transfer of such information to the Company’s business contacts outside the European Economic Area in order to further its business
interests. 
 Induction 
 Following your appointment, the Company provided an
induction programme which included meetings with senior management and the Company’s auditor and focussed on areas of specific interest to you. As part of your induction and during your term in office you received briefings on your duties as a
director generally and as a director of a company listed in the UK and HK. You also subsequently received a briefing on your obligations as a PRA Approved Person. 

Board evaluation 
 The performance of individual Directors and the whole Board
and its Committees is evaluated annually. If, in the interim, there are any matters which cause you concern about your role you should discuss them with me as soon as is appropriate. 

Professional development 
 As a Director you are invited to appropriate
educational and/or professional development programmes from time to time. The Company Secretary will consult each director annually to ascertain their specific professional development needs. 

  
 42 








 Directors’ and officers’ protection 

The Company has directors’ and officers’ liability insurance and it is intended to maintain such cover for the full term of your appointment. A brief summary of
the cover can be found in Prudential’s Guidance Notes for Directors, which is updated on a regular basis. 
 The Company has also provided you with indemnity
cover for directors’ and officers’ liability within the limitations imposed by law. In addition, the Company will provide you with a limited indemnity for certain personal liabilities you may suffer in the course of your appointment,
subject again to applicable statutory and other limitations, pursuant to the Company’s constitutional documents or otherwise. 
 The Board has also resolved to
have a discretionary payments policy (subject to regular review), the existence of which Directors (executive and non-executive) and certain employees or members of the Prudential Group may rely on, to protect
them from personal liability arising out of the bona fide performance of their duties on behalf of the Group. 
 Independent professional advice 

Occasions may arise when you consider that you need professional advice in the furtherance of your duties as a Director, and it may be appropriate for you to seek advice
from independent advisers at the Company’s expense. This would normally be arranged through the Company Secretary. The Company will reimburse the full cost of expenditure incurred in accordance with the policy. Details of the agreed procedure
under which Directors may obtain such independent advice can be found in the Prudential Guidance Notes for Directors. 
 Governing law and jurisdiction 

This letter and any non-contractual obligations arising out of or in connection with it shall be governed by English law. The
English courts have exclusive jurisdiction to settle any dispute arising in respect of it. 
 Yours sincerely 

/s/ Paul Manduca 
 Paul Manduca 

Chairman 
 Prudential plc 

  
 43 








 Acknowledgement: 
  

	1.	By signing this letter, I agree to its terms. 

  

	2.	I acknowledge that this appointment letter does not constitute a contract of employment. 

  

	3.	I confirm that by having accepted this appointment, I am able to allocate sufficient time to meet the demands of the role. 


Signed: /s/ Anthony Nightingale 
 Dated: 23.02.2014 

  
 44 








 Anthony Nightingale 

Schedule 1 – Committee memberships as at 1 July 2016 
  

	 	•	 	Remuneration Committee (Chairman) 

  

	 	•	 	Nomination Committee 

 Schedule 2 – time commitment and fees as at 1 July 2016 

 

													
	 	  	 	 	  	Number of
regular
scheduled
meetings	  	Approximate
time
commitment	  	Fees per
annum	 
	 Board
	  				  	8	  	31 days	  	£	95,000	 
	 Audit

Committee
	  	 
	Chairman
Member	 
 	  	5	  	22.5-27.5 days
 15 days
	  	£
 £
	75,000
 27,500
	 
  

	 Risk

Committee
	  	 
	Chairman
Member	 
 	  	5	  	19-24 days
 7.5 days
	  	£
 £
	75,000
 27,500
	 
  

	 Remuneration

Committee
	  	 
	Chairman
Member	 
 	  	4	  	18-23 days
 5 days
	  	£
 £
	60,000
 27,500
	 
  

	 Nomination

Committee
	  	 	Member	 	  	2	  	4 days	  	£	10,000	 
	 Senior Independent Director
	  				  		  	10-25 days	  	£	50,000	 

 Note: 
 In addition to the regular scheduled
meetings, the Committees may hold additional shorter meetings as relevant to discuss, for example, periodic financial reports, succession planning and other issues as they arise. 

  
 45 








 Exhibit 4.6 

13 February 2014 
 Dear Philip 

PRUDENTIAL PLC - LETTER OF APPOINTMENT 
 This letter supersedes your previous
letter of appointment dated 19 December 2012. The Board of Prudential plc (the ‘Company’) appointed you as Non-executive Director with effect from 1 January 2013. I am now writing to set out the revised terms of your appointment.
It is agreed that this is a contract for services subject to the Company’s Articles of Association as amended from time to time and does not constitute a contract of employment. 

Appointment 
 Your appointment was subject to election by shareholders at the
AGM in 2013 and to receipt of all necessary legal and regulatory approvals. Continuation of your appointment will be contingent on satisfactory performance, re-election at forthcoming AGMs and any statutory provisions relating to the removal of
directors. Non-executive Directors are appointed on the understanding that they serve an initial term of three years and, subject to review by the Nomination Committee, a second term of three years, both subject to annual election at the AGM. After
six years of service, Non-executive Directors may be appointed for a further year, up to a maximum of three years, subject to an annual review by the Nomination Committee. Good governance does not support the practice of serving longer than nine
years on the Board as a Non-executive Director. 
 If you are not confirmed or re-elected as a director by shareholders, or you are retired from office under the
Company’s Articles of Association, your appointment shall terminate automatically with immediate effect. 
 Participation in Committees 

Non-executive members of the Board are invited to serve on Committees of the Board, as determined by the Board from time to time. The principal Committees are Audit,
Risk, Remuneration and Nomination. The Schedule to this letter, as amended from time to time, lists the Committees of which you are a member. 
 Role 

Non-executive Directors have the same general legal responsibilities to the Company as any other Director. The Board as a whole is collectively responsible for the
success of the Company. The Board: 

  
 46 









	•	 	Provides entrepreneurial leadership of the Company within a framework of prudent and effective controls which enable risk to be assessed and managed; 


 

	•	 	Sets the Company’s strategic aims, ensures that the necessary financial, human and other resources are in place for the Company to meet its objectives, and reviews management performance; and 


 

	•	 	Sets the Company’s values and standards and ensures that its obligations to its shareholders and others are understood and met. 


Directors of any company must take decisions objectively in the interests of that company. As a director, you owe a fiduciary duty to the Company, which includes an
obligation not to do anything that might bring it into disrepute. A summary of responsibilities of Directors as applicable to the Company under current legislation will be provided to you. 

In addition to these general requirements of all Directors, the role of the Non-executive Director has the following key elements: 

 

	 	•	 	Strategy. Non-executive Directors should constructively challenge and help develop proposals on strategy. 

  

	 	•	 	Performance. Non-executive Directors should scrutinise the performance of management in meeting agreed goals and objectives and monitor the reporting of performance. This is achieved both at the Board and on a
more individual level through the Remuneration Committee. 

  

	 	•	 	Risk. Non-executive Directors should satisfy themselves of the integrity of financial information and that financial controls and systems of risk management are robust and defensible. This is achieved by
escalating key issues to the Board either directly or via the Audit Committee. The Group Risk Committee also has an important role in this context. 

  

	 	•	 	People. Non-executive Directors have a prime role in appointing, and where necessary removing, Executive Directors and in succession planning. In addition, they are responsible for determining appropriate levels
of remuneration for Executive Directors. This business is mainly conducted via the Nomination and Remuneration Committees. Non-executive Directors also have a prime role in upholding high standards of integrity and probity and in supporting the
other directors in instilling the appropriate culture, values and behaviours in the boardroom and beyond. 

 In this role, you will be a PRA Approved
Person, holding a Non-executive Director controlled function (CF2) in respect of The Prudential Assurance Company Limited (“PAC”). As an Approved Person, you must: 
  

	 	•	 	comply with the Statements of Principle and Code of Practice for Approved Persons (“APER”) set out in the APER section of the PRA Handbook; and 


 

	 	•	 	meet on an ongoing basis the fit and proper person test for Approved Persons (which covers honesty, integrity and reputation; competence and capability; and financial soundness). 


  
 47 








 Group Compliance has provided you with guidance on the obligations of Approved Persons and how these apply to your role as a
Controlled Function holder in respect of PAC. 
 Time Commitment and fees 

Time commitment will depend on the Committees on which you serve and may change over time, depending on the issues faced by the business and your time in the role. The
Schedule to this letter provides the current time expectations for Board and Committee membership. The Schedule is reviewed on an annual basis and may be amended from time to time by the Company. 

Whilst we acknowledge that you have other commitments which may mean you will not be able to attend all meetings of the Board and relevant Committees, you have confirmed
by accepting this appointment that you are able to allocate sufficient time to the Company’s affairs to meet the demands of the role. You must discuss any additional commitments that might impact on the time you are able to devote to your role
as a Non-executive Director of the Company with me prior to accepting. 
 Non-executive Directors’ fees are subject to annual review by the Board, and will be in
accordance with the policy approved by shareholders from time to time, as required under the Companies Act 2006 (the “Approved Policy”). Fees accrue on a daily basis and are payable quarterly in arrears. The fees currently payable for
Board membership and the additional fees payable for other Committee memberships are set out in the Schedule to this letter, as amended from time to time. All fees are payable net of any tax and National Insurance contributions, where the Company is
required to deduct these. 
 As a Non-executive Director you are not entitled to participate in any of the Group’s executive remuneration programmes or pension
arrangements. 
 Directors are entitled to claim for business related expenses properly incurred by them in connection with their attendance at meetings of the Board
or Committees of the Board, general meetings or separate meetings of the holders of any class of shares or of debentures of the Company or otherwise in connection with the discharge of their duties. Documentary evidence of expenses incurred should
be submitted to my office for approval. 
 Senior Independent Director 
 You
have also been appointed to the role of Senior Independent Director and the additional time commitment and fees are set out in the Schedule, as amended from time to time. 

Shareholding, dealing and compliance 
 The 2,500 Prudential qualification shares
you purchased within your first year of appointment must be retained during the tenure of your office. 
 The Board has also set a shareholding guideline for
Non-executive Directors equivalent in value to the basic annual fee. This shareholding should be acquired within a three-year period of the appointment becoming effective, or from the date of the introduction of the policy if earlier. 

  
 48 








 During your term in office you are subject to Prudential’s Share Dealing Rules, full particulars of which can be found
in the Board Reading Room on your iPad. The rules incorporate all relevant obligations arising from the Company’s listing in HK and the UK, as well as other relevant legislation. These are updated as required to reflect changes in
legislation and regulations, and will provide you with the necessary guidance on the steps you need to take and other considerations relating to share dealings. 
 If
you have any questions on this please consult with Group Secretariat. 
 Conflicts of interests, independence and disclosure obligations 

It is accepted and acknowledged that you have business interests other than those of the Company and we have discussed these and agreed that no conflicts of interest
currently exist (other than those authorised by the Board as part of the appointment process). In the event that you become aware of any future potential conflicts of interest, please disclose these to me and the Company Secretary as soon as
apparent and also prior to accepting appointments. In particular we would not wish our Directors to serve on the Boards of financial services competitors. 
 The Board
of the Company has determined that you are independent according to the provisions of the UK Corporate Governance Code and the Hong Kong Listing Rules, supported by your declaration of independence, and you will be identified as such in the annual
report and other documentation. If you are a member of the Audit Committee, you have also confirmed your independence in respect of the Securities and Exchange Act of 1934 as it applies to members of an audit committee of a Foreign Private Issuer.
If circumstances change, and you believe that your independence may be in doubt, you should discuss this with me as soon as possible. 
 The Company has an obligation
to notify details of other directorships held by its directors during the past five years to various regulators on an annual basis, together with non-statutory offices. Any changes in your external appointments, including non-statutory offices,
should be notified to the Company Secretary on an ongoing basis. In particular, any changes in your directorships of other quoted companies worldwide need to be notified promptly, preferably the next business day, as the Company is required to
announce this to various stock exchanges. 
 Wrongdoing 
 You will immediately
report to the Board your own wrongdoing or the wrongdoing or proposed wrongdoing of any employee or Director of which you become aware. 

  
 49 








 Termination of appointment 
 The
appointment may be terminated by and at the discretion of either party upon six months’ written notice. On termination of your appointment you shall resign from your office as director of the Company and of any offices you hold in any of the
Company’s group companies. Upon termination you will not be entitled to any compensation, other than accrued pro-rata fees, and you shall also cease to be a member of any Committee of the Board. All records, documents, accounts, letters and
papers of every description (including in particular Board and Committee agendas, minutes and papers) within your possession or control relating to the affairs and business of the Group are and will remain the property of the Company, and shall be
returned to the Company forthwith on termination. 
 Notwithstanding the above, your appointment may be terminated with immediate effect if you: 

 

	(a)	commit a material breach of your obligations under this letter; or 

  

	(b)	commit any serious or repeated breach or non-observance of your obligations to the Company (which include an obligation not to breach your duties to the Company, whether statutory, fiduciary or common-law); or


  

	(c)	are guilty of any fraud or dishonesty or acted in a manner which, in the opinion of the Company acting reasonably, brings or is likely to bring you or the Company into disrepute or is materially adverse to the interests
of the Company; or 

  

	(d)	are convicted of any arrestable criminal offence other than an offence under road traffic legislation in the UK or elsewhere for which a fine or non-custodial penalty is imposed; or 


 

	(e)	are declared bankrupt or have made an arrangement with or for the benefit of your creditors; or 

  

	(f)	are disqualified from acting as a director; 

  

	(g)	cease to hold PRA Approved Person status ; or 

  

	(h)	do not comply with the Group Anti-Bribery and Corruption Policy. 

 Confidentiality 

During your appointment you will have access to confidential information regarding the business and financial affairs of the Company and those of its subsidiaries,
undertakings and affiliates. You must not, either during your appointment or afterwards, disclose to anyone or otherwise make use of this confidential information, except in the proper performance of your duties or as may be required by law or by
any competent regulatory body. This does not apply, however, to any information already in the public domain. 
 Your attention is also drawn to the requirements under
both legislation and regulation as to the disclosure of price sensitive information. Consequently you should avoid making any statements that might risk a breach of these requirements without prior clearance from me or the Company Secretary. 

  
 50 








 Data Protection 
 By signing this
letter, you consent to the Company holding and processing information about you for legal, personnel, administrative and management purposes and in particular to the processing of any sensitive personal data (as defined in the Data Protection Act
1998) including, as appropriate: 
  

	(a)	your racial or ethnic origin or religious or similar beliefs in order to monitor compliance with equal opportunities legislation; or 


 

	(b)	information relating to any criminal proceedings in which you have been involved for insurance purposes and in order to comply with legal requirements and obligations to third parties. 


You consent to the Company making such information available to any of its group companies, those who provide products or services to the Company (such as advisers and
payroll administrators), regulatory authorities, potential or future employers, governmental or quasi-governmental organisations and potential purchasers of the Company. 

You also consent to the transfer of such information to the Company’s business contacts outside the European Economic Area in order to further its business
interests. 
 Induction 
 Following your appointment, the Company provided an
induction programme which included meetings with senior management and the Company’s auditor and focussed on areas of specific interest to you. As part of your induction and during your term in office you received briefings on your duties as a
director generally and as a director of a company listed in the UK and HK. You also subsequently received a briefing on your obligations as a PRA Approved Person. 

Board evaluation 
 The performance of individual Directors and the whole Board
and its Committees is evaluated annually. If, in the interim, there are any matters which cause you concern about your role you should discuss them with me as soon as is appropriate. 

Professional development 
 As a Director you are invited to appropriate
educational and/or professional development programmes from time to time. The Company Secretary will consult each director annually to ascertain their specific professional development needs. 

  
 51 








 Directors’ and officers’ protection 

The Company has directors’ and officers’ liability insurance and it is intended to maintain such cover for the full term of your appointment. A brief summary of
the cover can be found in Prudential’s Guidance Notes for Directors, which is updated on a regular basis. 
 The Company has also provided you with indemnity
cover for directors’ and officers’ liability within the limitations imposed by law. In addition, the Company will provide you with a limited indemnity for certain personal liabilities you may suffer in the course of your appointment,
subject again to applicable statutory and other limitations, pursuant to the Company’s constitutional documents or otherwise. 
 The Board has also resolved to
have a discretionary payments policy (subject to regular review), the existence of which Directors (executive and non-executive) and certain employees or members of the Prudential Group may rely on, to protect them from personal liability arising
out of the bona fide performance of their duties on behalf of the Group. 
 Independent professional advice 

Occasions may arise when you consider that you need professional advice in the furtherance of your duties as a Director, and it may be appropriate for you to seek advice
from independent advisers at the Company’s expense. This would normally be arranged through the Company Secretary. The Company will reimburse the full cost of expenditure incurred in accordance with the policy. Details of the agreed procedure
under which Directors may obtain such independent advice can be found in the Prudential Guidance Notes for Directors. 
 Governing law and jurisdiction 

This letter and any non-contractual obligations arising out of or in connection with it shall be governed by English law. The English courts have exclusive jurisdiction
to settle any dispute arising in respect of it. 
 Yours sincerely 
 /s/ Paul
Manduca 
 Paul Manduca 
 Chairman 

Prudential plc 

  
 52 








 Acknowledgement: 
  

	1.	By signing this letter, I agree to its terms. 

  

	2.	I acknowledge that this appointment letter does not constitute a contract of employment. 

  

	3.	I confirm that by having accepted this appointment, I am able to allocate sufficient time to meet the demands of the role. 


Signed:/s/ Philip Remnant 
 Dated: February 2014 

  
 53 








 Hon P J Remnant 

Schedule 1 – Committee memberships as at 1 July 2016 
  

	 	•	 	Audit Committee 

  

	 	•	 	Remuneration Committee 

  

	 	•	 	Nomination Committee 

  

	 	•	 	Senior Independent Director 

 Schedule 2 – time commitment and fees as at 1 July 2016 

 

											
	 	  	 	  	Number of
regular
scheduled
meetings	 	  	Approximate
time
commitment	  	 Fees per
annum

	 Board
	  		  	 	8	 	  	31 days	  	£95,000
	 Audit Committee
	  	Chairman Member	  	 	5	 	  	22.5-27.5 days
 15 days
	  	£75,000 £27,500
	 Risk Committee
	  	Chairman Member	  	 	5	 	  	19-24 days
 7.5 days
	  	£75,000 £27,500
	 Remuneration Committee
	  	Chairman Member	  	 	4	 	  	18-23 days
 5 days
	  	£60,000 £27,500
	 Nomination Committee
	  	Member	  	 	2	 	  	4 days	  	£10,000
	 Senior Independent Director
	  		  				  	10-25 days	  	£50,000

 Note: 
 In addition to the regular scheduled
meetings, the Committees may hold additional shorter meetings as relevant to discuss, for example, periodic financial reports, succession planning and other issues as they arise. 

  
 54 








 Exhibit 4.6 

13 February 2014 
 Dear Alice 

PRUDENTIAL PLC - LETTER OF APPOINTMENT 
 This letter supersedes your previous
letter of appointment dated 12 June 2013. The Board of Prudential plc (the ‘Company’) appointed you as Non-executive Director with effect from 10 June 2013. I am now writing to set out the revised terms of your appointment. It is
agreed that this is a contract for services subject to the Company’s Articles of Association as amended from time to time and does not constitute a contract of employment. 

Appointment 
 Your appointment is subject to election by shareholders at the AGM
in 2014 and to receipt of all necessary legal and regulatory approvals. Continuation of your appointment will be contingent on satisfactory performance, re-election at forthcoming AGMs and any statutory provisions relating to the removal of
directors. Non-executive Directors are appointed on the understanding that they serve an initial term of three years and, subject to review by the Nomination Committee, a second term of three years, both subject to annual election at the AGM. After
six years of service, Non-executive Directors may be appointed for a further year, up to a maximum of three years, subject to an annual review by the Nomination Committee. Good governance does not support the practice of serving longer than nine
years on the Board as a Non-executive Director. 
 If you are not confirmed or re-elected as a director by shareholders, or you are retired from office under the
Company’s Articles of Association, your appointment shall terminate automatically with immediate effect. 
 Participation in Committees 

Non-executive members of the Board are invited to serve on Committees of the Board, as determined by the Board from time to time. The principal Committees are Audit,
Risk, Remuneration and Nomination. The Schedule to this letter, as amended from time to time, lists the Committees of which you are a member. 

  
 55 








 Role 
 Non-executive Directors have
the same general legal responsibilities to the Company as any other Director. The Board as a whole is collectively responsible for the success of the Company. The Board: 
  

	•	 	Provides entrepreneurial leadership of the Company within a framework of prudent and effective controls which enable risk to be assessed and managed; 


 

	•	 	Sets the Company’s strategic aims, ensures that the necessary financial, human and other resources are in place for the Company to meet its objectives, and reviews management performance; and 


 

	•	 	Sets the Company’s values and standards and ensures that its obligations to its shareholders and others are understood and met. 


Directors of any company must take decisions objectively in the interests of that company. As a director, you owe a fiduciary duty to the Company, which includes an
obligation not to do anything that might bring it into disrepute. A summary of responsibilities of Directors as applicable to the Company under current legislation will be provided to you. 

In addition to these general requirements of all Directors, the role of the Non-executive Director has the following key elements: 

 

	 	•	 	Strategy. Non-executive Directors should constructively challenge and help develop proposals on strategy. 

  

	 	•	 	Performance. Non-executive Directors should scrutinise the performance of management in meeting agreed goals and objectives and monitor the reporting of performance. This is achieved both at the Board and on a
more individual level through the Remuneration Committee. 

  

	 	•	 	Risk. Non-executive Directors should satisfy themselves of the integrity of financial information and that financial controls and systems of risk management are robust and defensible. This is achieved by
escalating key issues to the Board either directly or via the Audit Committee. The Group Risk Committee also has an important role in this context. 

  

	 	•	 	People. Non-executive Directors have a prime role in appointing, and where necessary removing, Executive Directors and in succession planning. In addition, they are responsible for determining appropriate levels
of remuneration for Executive Directors. This business is mainly conducted via the Nomination and Remuneration Committees. Non-executive Directors also have a prime role in upholding high standards of integrity and probity and in supporting the
other directors in instilling the appropriate culture, values and behaviours in the boardroom and beyond. 

 In this role, you will be a PRA Approved
Person, holding a Non-executive Director controlled function (CF2) in respect of The Prudential Assurance Company Limited (“PAC”). As an Approved Person, you must: 
  

	 	•	 	comply with the Statements of Principle and Code of Practice for Approved Persons (“APER”) set out in the APER section of the PRA Handbook; and 


 

	 	•	 	meet on an ongoing basis the fit and proper person test for Approved Persons (which covers honesty, integrity and reputation; competence and capability; and financial soundness). 


  
 56 








 Group Compliance has provided you with guidance on the obligations of Approved Persons and how these apply to your role as a
Controlled Function holder in respect of PAC. 
 Time Commitment and fees 

Time commitment will depend on the Committees on which you serve and may change over time, depending on the issues faced by the business and your time in the role. The
Schedule to this letter provides the current time expectations for Board and Committee membership. The Schedule is reviewed on an annual basis and may be amended from time to time by the Company. 

Whilst we acknowledge that you have other commitments which may mean you will not be able to attend all meetings of the Board and relevant Committees, you have confirmed
by accepting this appointment that you are able to allocate sufficient time to the Company’s affairs to meet the demands of the role. You must discuss any additional commitments that might impact on the time you are able to devote to your role
as a Non-executive Director of the Company with me prior to accepting. 
 Non-executive Directors’ fees are subject to annual review by the Board, and will be in
accordance with the policy approved by shareholders from time to time, as required under the Companies Act 2006 (the “Approved Policy”). Fees accrue on a daily basis and are payable quarterly in arrears. The fees currently payable for
Board membership and the additional fees payable for other Committee memberships are set out in the Schedule to this letter, as amended from time to time. All fees are payable net of any tax and National Insurance contributions, where the Company is
required to deduct these. 
 As a Non-executive Director you are not entitled to participate in any of the Group’s executive remuneration programmes or pension
arrangements. 
 Directors are entitled to claim for business related expenses properly incurred by them in connection with their attendance at meetings of the Board
or Committees of the Board, general meetings or separate meetings of the holders of any class of shares or of debentures of the Company or otherwise in connection with the discharge of their duties. Documentary evidence of expenses incurred should
be submitted to my office for approval. 
 Shareholding, dealing and compliance 

The 2,500 Prudential qualification shares you purchased within your first year of appointment must be retained during the tenure of your office. 

  
 57 








 The Board has also set a shareholding guideline for Non-executive Directors equivalent in value to the basic annual fee.
This shareholding should be acquired within a three-year period of the appointment becoming effective, or from the date of the introduction of the policy if earlier. 

During your term in office you are subject to Prudential’s Share Dealing Rules, full particulars of which can be found in the Board Reading Room on your iPad. The
rules incorporate all relevant obligations arising from the Company’s listing in HK and the UK, as well as other relevant legislation. These are updated as required to reflect changes in legislation and regulations, and will provide you
with the necessary guidance on the steps you need to take and other considerations relating to share dealings. 
 If you have any questions on this please consult with
Group Secretariat. 
 Conflicts of interests, independence and disclosure obligations 

It is accepted and acknowledged that you have business interests other than those of the Company and we have discussed these and agreed that no conflicts of interest
currently exist (other than those authorised by the Board as part of the appointment process). In the event that you become aware of any future potential conflicts of interest, please disclose these to me and the Company Secretary as soon as
apparent and also prior to accepting appointments. In particular we would not wish our Directors to serve on the Boards of financial services competitors. 
 The Board
of the Company has determined that you are independent according to the provisions of the UK Corporate Governance Code and the Hong Kong Listing Rules, supported by your declaration of independence, and you will be identified as such in the annual
report and other documentation. If you are a member of the Audit Committee, you have also confirmed your independence in respect of the Securities and Exchange Act of 1934 as it applies to members of an audit committee of a Foreign Private Issuer.
If circumstances change, and you believe that your independence may be in doubt, you should discuss this with me as soon as possible. 
 The Company has an obligation
to notify details of other directorships held by its directors during the past five years to various regulators on an annual basis, together with non-statutory offices. Any changes in your external appointments, including non-statutory offices,
should be notified to the Company Secretary on an ongoing basis. In particular, any changes in your directorships of other quoted companies worldwide need to be notified promptly, preferably the next business day, as the Company is required to
announce this to various stock exchanges. 
 Wrongdoing 
 You will immediately
report to the Board your own wrongdoing or the wrongdoing or proposed wrongdoing of any employee or Director of which you become aware. 

  
 58 








 Termination of appointment 
 The
appointment may be terminated by and at the discretion of either party upon six months’ written notice. On termination of your appointment you shall resign from your office as director of the Company and of any offices you hold in any of the
Company’s group companies. Upon termination you will not be entitled to any compensation, other than accrued pro-rata fees, and you shall also cease to be a member of any Committee of the Board. All records, documents, accounts, letters and
papers of every description (including in particular Board and Committee agendas, minutes and papers) within your possession or control relating to the affairs and business of the Group are and will remain the property of the Company, and shall be
returned to the Company forthwith on termination. 
 Notwithstanding the above, your appointment may be terminated with immediate effect if you: 

 

	(a)	commit a material breach of your obligations under this letter; or 

  

	(b)	commit any serious or repeated breach or non-observance of your obligations to the Company (which include an obligation not to breach your duties to the Company, whether statutory, fiduciary or common-law); or


  

	(c)	are guilty of any fraud or dishonesty or acted in a manner which, in the opinion of the Company acting reasonably, brings or is likely to bring you or the Company into disrepute or is materially adverse to the interests
of the Company; or 

  

	(d)	are convicted of any arrestable criminal offence other than an offence under road traffic legislation in the UK or elsewhere for which a fine or non-custodial penalty is imposed; or 


 

	(e)	are declared bankrupt or have made an arrangement with or for the benefit of your creditors; or 

  

	(f)	are disqualified from acting as a director; 

  

	(g)	cease to hold PRA Approved Person status ; or 

  

	(h)	do not comply with the Group Anti-Bribery and Corruption Policy. 

 Confidentiality 

During your appointment you will have access to confidential information regarding the business and financial affairs of the Company and those of its subsidiaries,
undertakings and affiliates. You must not, either during your appointment or afterwards, disclose to anyone or otherwise make use of this confidential information, except in the proper performance of your duties or as may be required by law or by
any competent regulatory body. This does not apply, however, to any information already in the public domain. 

  
 59 








 Your attention is also drawn to the requirements under both legislation and regulation as to the disclosure of price
sensitive information. Consequently you should avoid making any statements that might risk a breach of these requirements without prior clearance from me or the Company Secretary. 

Data Protection 
 By signing this letter, you consent to the Company holding and
processing information about you for legal, personnel, administrative and management purposes and in particular to the processing of any sensitive personal data (as defined in the Data Protection Act 1998) including, as appropriate: 

 

	(a)	your racial or ethnic origin or religious or similar beliefs in order to monitor compliance with equal opportunities legislation; or 


 

	(b)	information relating to any criminal proceedings in which you have been involved for insurance purposes and in order to comply with legal requirements and obligations to third parties. 


You consent to the Company making such information available to any of its group companies, those who provide products or services to the Company (such as advisers and
payroll administrators), regulatory authorities, potential or future employers, governmental or quasi-governmental organisations and potential purchasers of the Company. 

You also consent to the transfer of such information to the Company’s business contacts outside the European Economic Area in order to further its business
interests. 
 Induction 
 Following your appointment, the Company provided an
induction programme which included meetings with senior management and the Company’s auditor and focussed on areas of specific interest to you. As part of your induction and during your term in office you received briefings on your duties as a
director generally and as a director of a company listed in the UK and HK. You also subsequently received a briefing on your obligations as a PRA Approved Person. 

Board evaluation 
 The performance of individual Directors and the whole Board
and its Committees is evaluated annually. If, in the interim, there are any matters which cause you concern about your role you should discuss them with me as soon as is appropriate. 

  
 60 








 Professional development 
 As a
Director you are invited to appropriate educational and/or professional development programmes from time to time. The Company Secretary will consult each director annually to ascertain their specific professional development needs. 

Directors’ and officers’ protection 
 The Company has directors’
and officers’ liability insurance and it is intended to maintain such cover for the full term of your appointment. A brief summary of the cover can be found in Prudential’s Guidance Notes for Directors, which is updated on a regular basis.

 The Company has also provided you with indemnity cover for directors’ and officers’ liability within the limitations imposed by law. In addition, the
Company will provide you with a limited indemnity for certain personal liabilities you may suffer in the course of your appointment, subject again to applicable statutory and other limitations, pursuant to the Company’s constitutional documents
or otherwise. 
 The Board has also resolved to have a discretionary payments policy (subject to regular review), the existence of which Directors (executive and
non-executive) and certain employees or members of the Prudential Group may rely on, to protect them from personal liability arising out of the bona fide performance of their duties on behalf of the Group. 

Independent professional advice 
 Occasions may arise when you consider that you
need professional advice in the furtherance of your duties as a Director, and it may be appropriate for you to seek advice from independent advisers at the Company’s expense. This would normally be arranged through the Company Secretary. The
Company will reimburse the full cost of expenditure incurred in accordance with the policy. Details of the agreed procedure under which Directors may obtain such independent advice can be found in the Prudential Guidance Notes for Directors. 

Governing law and jurisdiction 
 This letter and any non-contractual obligations
arising out of or in connection with it shall be governed by English law. The English courts have exclusive jurisdiction to settle any dispute arising in respect of it. 

Yours sincerely 
 /s/ Paul Manduca 

Paul Manduca 
 Chairman 

Prudential plc 

  
 61 








 Acknowledgement: 
  

	1.	By signing this letter, I agree to its terms. 

  

	2.	I acknowledge that this appointment letter does not constitute a contract of employment. 

  

	3.	I confirm that by having accepted this appointment, I am able to allocate sufficient time to meet the demands of the role. 


Signed: /s/ Alice Schroeder 
 Dated: 27.02.2014 

  
 62 








 Alice Schroeder 

Schedule 1 – Committee memberships as at 1 July 2016 
  

	 	•	 	Audit Committee 

 Schedule 2 – time commitment and fees as at 1 July 2016 

 

									
	 	  	 	  	Number
of regular
scheduled
meetings	  	Approximate
time commitment	  	Fees
per
annum
	 Board
	  		  	8	  	31 days	  	£95,000
	 Audit Committee
	  	Chairman Member	  	5	  	22.5-27.5 days
 15 days
	  	£75,000
 £27,500

	 Risk Committee
	  	Chairman Member	  	5	  	19-24 days
 7.5 days
	  	£75,000
 £27,500

	 Remuneration Committee
	  	Chairman Member	  	4	  	18-23 days
 5 days
	  	£60,000
 £27,500

	 Nomination Committee
	  	Member	  	2	  	4 days	  	£10,000
	 Senior Independent Director
	  		  		  	10-25 days	  	£50,000

 Note: 
 In addition to the regular scheduled
meetings, the Committees may hold additional shorter meetings as relevant to discuss, for example, periodic financial reports, succession planning and other issues as they arise. 

  
 63 








 Exhibit 4.6 

17 September 2015 
 Dear Adair 

PRUDENTIAL PLC - LETTER OF APPOINTMENT 
 I am delighted to confirm that the
Board of Prudential plc (the ‘Company’) has agreed to appoint you as Non-executive Director and member of the Audit Committee with effect from 15 September 2015. 

I am now writing to set out the terms of your appointment. It is agreed that this is a contract for services subject to the Company’s Articles of Association as
amended from time to time and does not constitute a contract of employment. 
 Appointment 

Your appointment is subject to election by shareholders at the AGM in 2016 and to receipt of all necessary legal and regulatory approvals. Continuation of your
appointment will be contingent on satisfactory performance, re-election at forthcoming AGMs and any statutory provisions relating to the removal of directors. Non-executive Directors are appointed on the understanding that they serve an initial term
of three years and, subject to review by the Nomination Committee, a second term of three years, both subject to annual election at the AGM. After six years of service, Non-executive Directors may be appointed for a further year, up to a maximum of
three years, subject to an annual review by the Nomination Committee. Good governance does not support the practice of serving longer than nine years on the Board as a Non-executive Director. 

If you are not confirmed or re-elected as a director by shareholders, or you are retired from office under the Company’s Articles of Association, your appointment
shall terminate automatically with immediate effect. 
 Participation in Committees 

Non-executive members of the Board are invited to serve on Committees of the Board, as determined by the Board from time to time. The principal Committees are Audit,
Risk, Remuneration and Nomination. The Schedule to this letter, as amended from time to time, lists the Committees of which you are a member. 
 Role 

Non-executive Directors have the same general legal responsibilities to the Company as any other Director. The Board as a whole is collectively responsible for the
success of the Company. The Board: 

  
 64 









	•	 	Provides entrepreneurial leadership of the Company within a framework of prudent and effective controls which enable risk to be assessed and managed; 


 

	•	 	Sets the Company’s strategic aims, ensures that the necessary financial, human and other resources are in place for the Company to meet its objectives, and reviews management performance; and 


 

	•	 	Sets the Company’s values and standards and ensures that its obligations to its shareholders and others are understood and met. 


Directors of any company must take decisions objectively in the interests of that company. As a director, you owe a fiduciary duty to the Company, which includes an
obligation not to do anything that might bring it into disrepute. A summary of responsibilities of Directors as applicable to the Company under current legislation will be provided to you. 

In addition to these general requirements of all Directors, the role of the Non-executive Director has the following key elements: 

 

	 	•	 	Strategy. Non-executive Directors should constructively challenge and help develop proposals on strategy. 

  

	 	•	 	Performance. Non-executive Directors should scrutinise the performance of management in meeting agreed goals and objectives and monitor the reporting of performance. This is achieved both at the Board and on a
more individual level through the Remuneration Committee. 

  

	 	•	 	Risk. Non-executive Directors should satisfy themselves of the integrity of financial information and that financial controls and systems of risk management are robust and defensible. This is achieved by
escalating key issues to the Board either directly or via the Audit Committee. The Group Risk Committee also has an important role in this context. 

  

	 	•	 	People. Non-executive Directors have a prime role in appointing, and where necessary removing, Executive Directors and in succession planning. In addition, they are responsible for determining appropriate levels
of remuneration for Executive Directors. This business is mainly conducted via the Nomination and Remuneration Committees. Non-executive Directors also have a prime role in upholding high standards of integrity and probity and in supporting the
other directors in instilling the appropriate culture, values and behaviours in the boardroom and beyond. 

 In this role, you are a PRA Approved Person,
holding a Non-executive Director controlled function (CF2) in respect of The Prudential Assurance Company Limited (“PAC”). As an Approved Person, you must: 
  

	 	•	 	comply with the Statements of Principle and Code of Practice for Approved Persons (“APER”) set out in the APER section of the PRA Handbook; and 


 

	 	•	 	meet on an ongoing basis the fit and proper person test for Approved Persons (which covers honesty, integrity and reputation; competence and capability; and financial soundness). 


  
 65 








 Group Compliance will provide you with guidance on the obligations of Approved Persons and how these apply to your role as a
Controlled Function holder in respect of PAC. 
 Time Commitment and fees 

Time commitment will depend on the Committees on which you serve and may change over time, depending on the issues faced by the business and your time in the role. The
Schedule to this letter provides the current time expectations for Board and Committee membership. The Schedule is reviewed on an annual basis and may be amended from time to time by the Company. 

Whilst we acknowledge that you have other commitments which may mean you will not be able to attend all meetings of the Board and relevant Committees, you have confirmed
by accepting this appointment that you are able to allocate sufficient time to the Company’s affairs to meet the demands of the role. You must discuss any additional commitments that might impact on the time you are able to devote to your role
as a Non-executive Director of the Company with me prior to accepting. 
 Non-executive Directors’ fees are subject to annual review by the Board, and will be in
accordance with the policy approved by shareholders from time to time, as required under the Companies Act 2006 (the “Approved Policy”). Fees accrue on a daily basis and are payable quarterly in arrears. The fees currently payable for
Board membership and the additional fees payable for other Committee memberships are set out in the Schedule to this letter, as amended from time to time. All fees are payable net of any tax and National Insurance contributions, where the Company is
required to deduct these. 
 As a Non-executive Director you are not entitled to participate in any of the Group’s executive remuneration programmes or pension
arrangements. 
 Directors are entitled to claim for business related expenses properly incurred by them in connection with their attendance at meetings of the Board
or Committees of the Board, general meetings or separate meetings of the holders of any class of shares or of debentures of the Company or otherwise in connection with the discharge of their duties. Documentary evidence of expenses incurred should
be submitted to my office for approval. 
 Shareholding, dealing and compliance 

You are required to hold 2,500 qualification shares in Prudential plc, which must be purchased within your first year of appointment must be retained during the tenure of
your office. 
 The Board has also set a shareholding guideline for Non-executive Directors equivalent in value to the basic annual fee. This shareholding should be
acquired within a three-year period of the appointment becoming effective. 

  
 66 








 During your term in office you are subject to Prudential’s Share Dealing Rules, full particulars of which can be found
in the Board Reading Room on your iPad. The rules incorporate all relevant obligations arising from the Company’s listing in HK and the UK, as well as other relevant legislation. These are updated as required to reflect changes in
legislation and regulations, and will provide you with the necessary guidance on the steps you need to take and other considerations relating to share dealings. 
 If
you have any questions on this please consult with Group Secretariat. 
 Conflicts of interests, independence and disclosure obligations 

It is accepted and acknowledged that you have business interests other than those of the Company and we have discussed these and agreed that no conflicts of interest
currently exist (other than those authorised by the Board as part of the appointment process). In the event that you become aware of any future potential conflicts of interest, please disclose these to me and the Company Secretary as soon as
apparent and also prior to accepting appointments. In particular we would not wish our Directors to serve on the Boards of financial services competitors. 
 The Board
of the Company has determined that you are independent according to the provisions of the UK Corporate Governance Code and the Hong Kong Listing Rules, supported by your declaration of independence, and you will be identified as such in the annual
report and other documentation. If you are a member of the Audit Committee, you have also confirmed your independence in respect of the Securities and Exchange Act of 1934 as it applies to members of an audit committee of a Foreign Private Issuer.
If circumstances change, and you believe that your independence may be in doubt, you should discuss this with me as soon as possible. 
 The Company has an obligation
to notify details of other directorships held by its directors during the past five years to various regulators on an annual basis, together with non-statutory offices held in a professional capacity. Any changes in your external appointments,
including non-statutory offices, should be notified to the Company Secretary on an ongoing basis. In particular, any changes in your directorships of other quoted companies worldwide need to be notified promptly, preferably the next business day, as
the Company is required to announce this to various stock exchanges. 
 Wrongdoing 

You will immediately report to the Board your own wrongdoing or the wrongdoing or proposed wrongdoing of any employee or Director of which you become aware. 

Termination of appointment 
 The appointment may be terminated by and at the
discretion of either party upon six months’ written notice. On termination of your appointment you shall resign from your office as director of the Company and of any offices you hold in any of the Company’s group companies. Upon
termination you will not be entitled to any compensation, other than accrued pro-rata fees, and you shall also cease to be a member of any Committee of the Board. All records, documents, accounts, letters and papers of every description (including
in 

  
 67 








 
particular Board and Committee agendas, minutes and papers) within your possession or control relating to the affairs and business of the Group are and will remain the property of the Company,
and shall be returned to the Company forthwith on termination. 
 Notwithstanding the above, your appointment may be terminated with immediate effect if you: 

 

	(a)	commit a material breach of your obligations under this letter; or 

  

	(b)	commit any serious or repeated breach or non-observance of your obligations to the Company (which include an obligation not to breach your duties to the Company, whether statutory, fiduciary or common-law); or


  

	(c)	are guilty of any fraud or dishonesty or acted in a manner which, in the opinion of the Company acting reasonably, brings or is likely to bring you or the Company into disrepute or is materially adverse to the interests
of the Company; or 

  

	(d)	are convicted of any arrestable criminal offence other than an offence under road traffic legislation in the UK or elsewhere for which a fine or non-custodial penalty is imposed; or 


 

	(e)	are declared bankrupt or have made an arrangement with or for the benefit of your creditors; or 

  

	(f)	are disqualified from acting as a director; or 

  

	(g)	cease to hold PRA Approved Person status ; or 

  

	(h)	do not comply with the Group Anti-Bribery and Corruption Policy. 

 Confidentiality 

During your appointment you will have access to confidential information regarding the business and financial affairs of the Company and those of its subsidiaries,
undertakings and affiliates. You must not, either during your appointment or afterwards, disclose to anyone or otherwise make use of this confidential information, except in the proper performance of your duties or as may be required by law or by
any competent regulatory body. This does not apply, however, to any information already in the public domain. 
 Your attention is also drawn to the requirements under
both legislation and regulation as to the disclosure of price sensitive information. Consequently you should avoid making any statements that might risk a breach of these requirements without prior clearance from me or the Company Secretary. 

  
 68 








 Data Protection 
 By signing this
letter, you consent to the Company holding and processing information about you for legal, personnel, administrative and management purposes and in particular to the processing of any sensitive personal data (as defined in the Data Protection Act
1998) including, as appropriate: 
  

	(a)	your racial or ethnic origin or religious or similar beliefs in order to monitor compliance with equal opportunities legislation; or 


 

	(b)	information relating to any criminal proceedings in which you have been involved for insurance purposes and in order to comply with legal requirements and obligations to third parties. 


You consent to the Company making such information available to any of its group companies, those who provide products or services to the Company (such as advisers and
payroll administrators), regulatory authorities, potential or future employers, governmental or quasi-governmental organisations and potential purchasers of the Company. 

You also consent to the transfer of such information to the Company’s business contacts outside the European Economic Area in order to further its business
interests. 
 Induction 
 Following your appointment, the Company will provide
an induction programme which will include meetings with senior management and the Company’s auditor and will focus on areas of specific interest to you. As part of your induction you will receive a briefing on your duties as a director
generally and as a director of a company listed in the UK and HK. You will also receive a briefing on your obligations as a PRA Approved Person. 
 Board evaluation

 The performance of individual Directors and the whole Board and its Committees is evaluated annually. If, in the interim, there are any matters which cause you
concern about your role you should discuss them with me as soon as is appropriate. 
 Professional development 

As a Director you are invited to appropriate educational and/or professional development programmes from time to time. The Company Secretary will consult each director
annually to ascertain their specific professional development needs. The Company will also provide you with relevant briefings affecting your duties as a director. 

  
 69 








 Directors’ and officers’ protection 

The Company has directors’ and officers’ liability insurance and it is intended to maintain such cover for the full term of your appointment. A brief summary of
the cover can be found in Prudential’s Guidance Materials for Directors, which are available on iPad. 
 The Company has also provided you with indemnity cover
for directors’ and officers’ liability within the limitations imposed by law. In addition, the Company will provide you with a limited indemnity for certain personal liabilities you may suffer in the course of your appointment, subject
again to applicable statutory and other limitations, pursuant to the Company’s constitutional documents or otherwise. 
 In addition, the Board has resolved to
have a discretionary payments policy (subject to regular review), the existence of which Directors (executive and non-executive) and certain employees or members of the Prudential Group may rely on, to protect them from personal liability arising
out of the bona fide performance of their duties on behalf of the Group. 
 Independent professional advice 

Occasions may arise when you consider that you need professional advice in the furtherance of your duties as a Director, and it may be appropriate for you to seek advice
from independent advisers at the Company’s expense. This would normally be arranged through the Company Secretary. The Company will reimburse the full cost of expenditure incurred in accordance with the policy. Details of the agreed procedure
under which Directors may obtain such independent advice can be found in the Prudential Guidance Materials for Directors. 
 Governing law and jurisdiction 

This letter and any non-contractual obligations arising out of or in connection with it shall be governed by English law. The English courts have exclusive jurisdiction
to settle any dispute arising in respect of it. 
 Yours sincerely 
 /s/ Paul
Manduca 
 Paul Manduca 
 Chairman 

Prudential plc 

  
 70 








 Acknowledgement: 
  

	1.	By signing this letter, I agree to its terms. 

  

	2.	I acknowledge that this appointment letter does not constitute a contract of employment. 

  

	3.	I confirm that by having accepted this appointment, I am able to allocate sufficient time to meet the demands of the role. 


Signed: /s/ Adair Turner 
 Dated: September 2015 

  
 71 








 Lord Turner 
 Schedule
1 – Committee memberships as at 1 July 2016 
  

	 	•	 	Risk Committee 

 Schedule 2 – time commitment and fees as at 1 July 2016 

 

									
	 	  	 	  	Number
of regular
scheduled
meetings	  	Approximate time
commitment	  	Fees
per
annum
	 Board
	  		  	8	  	31 days	  	£95,000
	 Audit Committee
	  	Chairman Member	  	5	  	22.5–27.5 days
 15 days
	  	£75,000
 £27,500

	 Risk Committee
	  	Chairman Member	  	5	  	19-24 days
 7.5 days
	  	£75,000
 £27,500

	 Remuneration Committee
	  	Chairman Member	  	4	  	18-23 days
 5 days
	  	£60,000
 £27,500

	 Nomination Committee
	  	Member	  	2	  	4 days	  	£10,000
	 Senior Independent Director
	  		  		  	10-25 days	  	£50,000

 Note: 
 In addition to the regular scheduled
meetings, the Committees may hold additional shorter meetings as relevant to discuss, for example, periodic financial reports, succession planning and other issues as they arise. 

  
 72